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The pathogen of Lyme disease, Borrelia burgdorferi, persists in a natural tick-
rodent infection cycle.  An assessment of microbial transcriptome in vivo encoding 
selected membrane proteins shows that bba52 is upregulated during pathogen 
transmission.  Deletion of bba52 in infectious B. burgdorferi did not alter the outcome of 
murine inflammation or long-term pathogen persistence in mice or ticks.  However, the 
bba52 mutant was impaired for transmission between feeding ticks and mice, phenotypic 
defects that could be rescued when bba52 was genetically restored to the original 
genomic locus. I show that BBA52 is a surface-exposed outer membrane protein.  As 
BBA52 is highly immunogenic, I next assessed whether BBA52 could serve as a 
potential candidate for transmission-blocking vaccines against spirochete infection.  
Passive transfer of BBA52 antibodies into the ticks did not interfere with microbial 
persistence in unfed ticks but blocked pathogen transmission from feeding ticks to murine 
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hosts.  More importantly, active immunization of mice with recombinant BBA52 protein 
significantly blocked B. burgdorferi transmission from ticks to naïve murine hosts.  As 
BBA52 antibodies lacked detectable borreliacidal activities, their interference with 
spirochete survival in vivo could result from the inhibition of BBA52 function, such as 
vector-pathogen interaction.  By far-western analysis using tick gut proteins, I found that 
BBA52 interacts with a ~ 35 kDa tick gut protein.  I also show that BBA52 forms distinct 
homo-oligomer in borrelial cells and also interacts with two proteins of B. burgdorferi. 
These BBA52 interacting proteins possess approximate molecular weight of 33 kDa and 
25 kDa and are located in the outer membrane and protoplasm, respectively. Taken 
together, these studies suggested the remarkable existence of B. burgdorferi surface 
antigens that are differentially expressed in vivo and support microbial transitions 
between hosts and the vector.  Identification and characterization of novel vector-specific 
and feeding induced borrelial antigens could contribute to the development of 
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Chapter 1: Introduction 
 
Background: Borrelia burgdorferi, a bacterium that has been classified under the family 
Spirochetaceae is the causative agent of a highly-prevalent vector borne disease 
transmitted by bite of Ixodes scapularis ticks and known as Lyme disease or Lyme 
borreliosis.  The disease has been named according to the place Lyme County in 
Connecticut, where the first detail study on this disease was initiated in early 1980.  The 
scientific research on Lyme disease has proceded at a rapid rate since the identification of 
the causative agent B. burgdorferi in 1982.  B. burgdorferi has developed differential 
strategies to survive in the vector and mammalian host environment, for example, the 
pathogen alter its gene expression profiles as it navigate through tick-mammal infection 
cycle.  With the recent advancement in technologies for assessment of gene expression, a 
number of genes have been identified to play critical roles in maintaining B. burgdorferi 
through natural enzootic cycle.  This chapter will review the literature about past studies 
that identified the role of specific genes in the pathogenesis of Lyme disease.  
1.1 Lyme disease  
 
The incidence of Lyme disease came to light in the year 1975 when two mothers, 
Polly Murray and Judith Mensch, from Lyme, Connecticut reported about the number of 
incidence of juvenile rheumatoid arthritis.  Thereafter, Borrelia burgdorferi was isolated 
by Willy Burgdorfer in the year 1982 from the Ixodes ticks (Burgdorfer et al., 1982).  
Shortly after, B. burgdorferi was cultivated from cerebrospinal fluids of patients 
suffering from Lyme disease (Barbour, 1984).  Further investigations against Lyme 
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disease revealed that approximately one-quarter of the patients had developed 
erythematous cutaneous lesion that in some cases appeared to expand into reddish, often 
annular, concentric rings, known as erythema migrans, which is the only distinguished 
clinical symptoms of Borrelia burgdorferi infection in humans.  
1.1.1 Geographical distribution 
Currently, Lyme disease is regarded as the most common vector borne disease in 
Northern hemisphere (Steere et al., 2004) and also in Eurasia (Piesman and Eisen, 
2008a).  According to the CDC, there has been increasing tendency of Lyme disease 
prevalence from the year 1995-2009 in the United States.  Most cases occurred in the 
following 10 northeastern, mid-Atlantic, and north-central states: Connecticut, Delaware, 
Maryland, Massachusetts, Minnesota, New Jersey, New York, Pennsylvania, Rhode 
Island, and Wisconsin (Hanincova et al., 2008).  The causative agent of Lyme disease in 
North America is caused by a wide range of B. burgdorferi isolates, collectively referred 
as B. burgdorferi sensu stricto complex.  In Europe, major borrelial isolates includes 3 
major strains, Borrelia burgdorferi, B. garinii and B. afzelli (Piesman and Gern, 2004), 
collectively known as Borrelia burgdorferi sensu lato complex.  The trend of focal cases 
of Lyme diseases coincides with the increase in the prevalence of Ixodes scapularis and 
deer population in the area. 
1.1.2 Clinical manifestation and treatment 
The spectrum of clinical manifestations resulting from infection with B. 
burgdorferi is generally termed as Lyme disease in United States and Lyme borreliosis in 
Europe and Asia (Rosa et al., 2005).  Lyme disease typically begins with a unique skin 
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lesion, erythema chronicum migrans (ECM) which is caused at the site of tick bite and is 
described to be pathognomonic symptom (Stage 1).  Patients with this lesion may also 
have a variety of non-specific clinical manifestations including headache, meningeal 
irritation, mild encephalopathy, multiple annular secondary lesions, malar or urticarial 
rash, generalized lymphadenopathy and splenomegaly, migratory musculoskeletal pain, 
hepatitis, sore throat, non-productive cough, conjunctivitis, periorbital edema, or 
testicular swelling (Steere et al., 1986).  After a few weeks to months (Stage 2), few 
patients develop frank neurologic abnormalities, including meningitis, encephalitis, 
cranial neuritis (including bilateral facial palsy), motor or sensory radiculoneuritis, 
mononeuritis multiplex, or myelitis (Steere et al., 1986).  At this time, some patients 
develop cardiac involvement primarily reflected as atrioventricular block, acute 
myopericarditis, cardiomegaly, or pancarditis (Steere et al., 1986).  Throughout this 
stage, many patients continue to experience migratory musculoskeletal pain in joints, 
tendons, bursae, muscle, or bone.  Months to years after initial disease onset (Stage 3), 
about 60% of patients develop arthritis, which may be intermittent or chronic.  Thus, 
Lyme disease occurs in stages with different clinical manifestations at each stage, but the 
course of the illness in each patient is highly variable.  Lyme disease can be efficiently 
treated at the early stage by the use of antibiotics.  Treatment becomes more challenging 
as the disease progresses and reaches late stage.  Antibiotic Doxycycline which is a 
Tetracycline derivative is routinely used to treat Lyme borreliosis (Pavia, 2003; Stricker 
et al., 2006).  A 2 to 4-week course of antibiotics is generally effective therapy for the 
localized and early-disseminated stages of Lyme disease.  However, a subset of patients 
requires longer antibiotic treatment and can develop chronic symptoms that are 
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unresponsive to antibiotics, possibly as post-infectious autoimmune sequelae (Steere, 
2001).  If untreated, Lyme disease can progress to Stage 3, or late-persistent disease, with 
chronic arthritis, neuroborreliosis and skin disorders.  A recombinant vaccine against 
OspA was developed (Steere et al., 1998) but was retracted from the market by the 
manufacturer due to sales related issues.  Vaccination with OspA caused potential 
autoimmune arthritis (Abbott, 2006; Nordstrand et al., 2000) and also was low in 
efficiency because people required frequent boosters to maintain effective antibody titers 
to confer protection.  
1.2 General features of B. burgdorferi 
B. burgdorferi spirochetes are Gram negative,  highly motile, spiral-shaped and 
elongated with variable length (~10-30 μm), thin (~0.3 μm in width) bacteria, which can 
be visualized under dark field microscopy (Goldstein et al., 1996).  It has characteristic 
periplasmic 7-11 bipolar endoflagella attached to the poles of the bacterial cell (Barbour 
and Hayes, 1986; Goldstein et al., 1996; Motaleb et al., 2000), which plays an important 
role in cell shape (Motaleb et al., 2000)  and chemotaxis (Shi et al., 1998) to different 
organs of  host it invades.  These flagella also attribute flat wave-like shape to the 
organism (Charon et al., 2009).  B. burgdorferi is an obligate extracellular bacterium, not 
able to endure itself outside arthropod vector or vertebrate host, except for artificial 
laboratory culture medium.  B. burgdorferi has fastidious growth requirements for in 
vitro cultivation.  In laboratory, B. burgdorferi can be cultivated only in  highly enriched 
medium, Barbour-Stoenner-Kelly II (BSK II) supplemented with the rabbit serum 
(Barbour, 1984).  B. burgdorferi cultures are grown in a microaerophilic environment 
(1.5% CO2) at 34°C.  The natural reservoir host for the B. burgdorferi is wild rodents, 
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most commonly the white footed mouse (Peromyscus leucopus).  Humans and many 
other domestic animals are the accidental hosts that are infected by I. scapularis ticks.  
Ticks both acquire and transmit B. burgdorferi by feeding on a variety of small mammals 
that act as reservoir hosts (Magnarelli et al., 1988).  Although B. burgdorferi is often 
referred as Gram-negative because they have both an outer and inner membrane, they 
share many features of Gram-positive bacteria. These include the low G+C content of the 
genome (28.6%) (Fraser et al., 1997b) and the close association of the inner membrane 
with a peptidoglycan cell wall.  Unlike other Gram-negative bacteria, the B. burgdorferi 
outer membrane (OM) is very distinct in the sense that it lacks lipopolysacharides 
(Takayama et al., 1987) and the membrane is very fluid and labile consisting of 45-62% 
protein, 23-50% lipid and 3-4% carbohydrate (Barbour and Hayes, 1986).  B. burgdorferi 
OM also houses a lower density of membrane-spanning proteins but  possesses a large 
number of membrane-anchored proteins that remain attached to outer or inner leaflet of 
the OM via amino-terminal lipid moiety.  
1.3 Genome of B. burgdorferi  
 
B. burgdorferi is classified under family Spirochetaceae due to its fascinating 
spiral shape.  The members of genus Borrelia whose genome sequences have been 
determined till now are B. burgdorferi, B. garinii, B. afzelii, B. duttonii and B. 
recurrentis.  Recently, whole genome sequences of 13 additional B. burgdorferi isolates 
were also derived (Schutzer et al., 2010).   All the members of B. burgdorferi sensu lato 
identified till date harbors a linear chromosome in the range of about 900 kilobase pair 
(kbp) in length and a plethora of linear and circular extra chromosomal DNA elements or 
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plasmids.  Lyme pathogens maintains highest number of known extrachromosomal 
plasmids known till now in any bacterium (Rosa et al., 2005).  Among all these, B. 
burgdorferi strain B31, the B. burgdorferi type strain, has been studied in more detail, 
and harbours 12 linear and 9 circular plasmids that constitute about 612 kbp.  The 
chromosomes harbors mostly homologous genes, whereas the plasmids are more 
variable, which also possess greater number of paralogous sequences, pseudo genes in 
addition to possession of certain essential genes.  These features have been observed 
directly for eight of the Borrelia species, B. burgdorferi, B. bissettii, B. garinii, B. afzelii, 
B. andersonii, B. valaisiana, B. lusitaniae, and B. japonica, as well as the relapsing fever 
species B. hermsii, B. turicatae, B. duttonii, B. recurrentis, B. coriaceae, B. parkeri, and 
B. anserina (Casjens et al., 1995; Casjens and Huang, 1993; Davidson et al., 1992; 
Ferdows and Barbour, 1989; Kitten et al., 1993; Lescot et al., 2008; Ojaimi et al., 1994).  
The chromosome bears tightly packed genes with overlapping genes or with less 
intergenic sequences like other typical prokaryotes, while many of the linear plasmids 
have substantially lower gene densities with longer intergenic regions and many 
apparently  represent decaying pseudogenes (Casjens, 2000).  It is speculated that the 
stable chromosome encodes the proteome machinery required for basic cellular 
machinery.  In contrast, the relatively unstable and evolutionarily variable plasmids 
encode most proteins that interact with the vertebrate and arthropod host environments 
encountered by the bacteria during its enzootic cycle.  Pathogenic bacteria often carries 
plasmids encoding genes which are important for infection to the host but the plasmid 
encoding genes in B. burgdorferi have no similarity with other bacterial virulence genes 
(Casjens, 2000).  This supports the notion that B. burgdorferi plasmids encode genes with 
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functions that are specific to spirochete infectious cycle, and the B. burgdorferi host-
pathogen interactions.  This fostered the hypothesis that B. burgdorferi host–pathogen 
interactions are different from those of other well-studied bacterial pathogens (Casjens, 
2000).  
B. burgdorferi extrachromosomal plasmids vary in stability, some of which could 
be lost after a few generation of in vitro culture while others are stably maintained 
(Byram et al., 2004; Grimm et al., 2003; Schwan et al., 1988; Xu et al., 1996).  The loss 
of plasmids during in vitro growth results in difference in the multiplication of B. 
burgdorferi in vivo as some plasmids encodes for genes that are critical for survival in the 
natural host while the other plasmids have no effect on infectious cycle (Elias et al., 
2002a; Labandeira-Rey and Skare, 2001; Purser and Norris, 2000).  In genetic studies, as 
bacterial growth in culture cannot be avoided, care must be taken to assure that there is 
no plasmid loss during genetic manipulation (Rosa et al., 2005). 
 
1.4  B. burgdorferi gene expression and development of genetic tools in spirochete 
research 
1.4.1  B. burgdorferi gene expression 
The advent of global transcriptional microarray analyses has provided important 
insight into how B. burgdorferi modulates its gene expression to various experimental 
conditions or environmental stimuli that either individually or collectively simulates a 
host-adapted condition.  Although details of how majority of B. burgdorferi genes are 
transcriptionally regulated during tick-rodent infection cycle is still unclear, several 
regulatory proteins, including sigma factors, DNA-binding proteins, and transcriptional 
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activators/repressors that either directly or indirectly control the differential expression of 





 sigma factor cascade (the Rrp2–RpoN–RpoS pathway) that plays a central role in 
modulating a dramatic switch in the gene expression program as B. burgdorferi is 
transmitted from its arthropod to vertebrate host.  There are two alternative sigma factors 
encoded in the B. burgdorferi genome, RpoN (σ
54





, encoded by rpoS; bb0771) (Fraser et al., 1997b).   Hubner et al., 
2001  generated an rpoS mutant and rpoN mutant in a low-passage infectious strain (B. 
burgdorferi strain 297) that resulted in the loss of OspC and DbpA/B, suggesting that 
RpoS and RpoN is required for the regulation of the genes encoding these surface 
lipoproteins.  Subsequent studies, including microarray analyses, revealed that RpoS 
influences expression of more than 100 genes (Caimano et al., 2007; Fisher et al., 2005; 
Ouyang et al., 2008).  Many RpoS-activated genes appear to be differentially expressed 
during tick feeding and some, including ospC, dbpBA, bbk32, oppA-V, bba64, and bba66, 
have been shown to be required for or associated with mammalian host infection (Clifton 
et al., 2006; Fischer et al., 2006; Fischer et al., 2003; Gautam et al., 2008; Gilmore et al., 
2007; Grimm et al., 2004b; Maruskova et al., 2008; Medrano et al., 2007; Seshu et al., 
2006; Shi et al., 2008; Weening et al., 2008).  In addition, 59 genes were upregulated and 
34 genes were downregulated by RpoS when spirochetes were cultivated within dialysis 
membrane chambers implanted into the peritoneal cavity of rats, which recapitulates the 
response to mammalian host signals (Akins et al., 1998; Caimano et al., 2007).  Although 
the Rrp2–RpoN–RpoS pathway controls expression of a vast network of genes and 
operons, there are still an abundant number of differentially expressed genes that are not 
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regulated by this cascade (Boardman et al., 2008).  This observation suggests that other 
DNA-binding proteins and/or transcriptional regulators must be expressed by B. 
burgdorferi and play important roles in regulating gene transcription. 
1.4.2 Development of genetic tools in B. burgdorferi research 
Genetic manipulation did not come underway until a decade following the 
isolation of B. burgdorferi.  Genetic studies in B. burgdorferi have been extremely 
difficult due to its fastidious growing condition, segmented genome part of which could 
be lost during in vitro propagation, lack of selectable markers, extremely low DNA 
transformation efficiency and evolutionary distance from other genetically tractable 
bacteria. The first successful B. burgdorferi transformation was reported by Samuels and 
coworkers in the year 1984 which is considered as a seminal contribution in the Lyme 
disease research.  Recently, molecular genetics approach has been applied with growing 
success to study the biology and the virulence of B. burgdorferi (Rosa et al., 2005; 
Sartakova et al., 2001; Tilly et al., 2000; Yang et al., 2009; Zhang et al., 2009).  
However, the generation of isogenic mutant and complemented clones still remains 
technically challenging, primarily due to the unstable nature of some of the essential 
plamids, multifactorial barriers to the uptake and incorporation of exogenous DNA and 
highly efficient restriction modification system.  Polar effects following insertional 
inactivation and allelic exchange can arise as a consequence of genetic manipulation, 
especially in cases of B. burgdorferi chromosome, which contains many genes with 
overlapping transcriptional and termination signals (Fraser et al., 1997b).  The presence 
of paralogous gene families encoding products with similar functions and with 
overlapping transcriptional signals, in B. burgdorferi also can complicate the 
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interpretation of mutant phenotypes (Casjens et al., 2000a).  Despite critical challenges, 
substantial progress has been made in utilizing a genetic approach to study factors 
involved in the biology and pathogenesis of B. burgdorferi. 
In B. burgdorferi, the gene of interest is inactivated mainly by three methods, 
allelic-exchange, plasmid integration or random genome-wide transposon mutagenesis.  
Historically, ospC  was the foremost gene to be inactivated in B. burgdorferi by allelic-
exchange  (Tilly et al., 1997) by means of the selective marker GyrB
r
, a mutated form of 
the chromosomal gyrB gene conferring resistance to coumermycin A1 (Samuels et al., 
1994).  Yet, coumermycin as a selectable marker is imperfect due to high frequency of 
recombination with the endogenous gyrB gene (Tilly et al., 1998).  Lately, an efficient 
selectable marker was developed by engineering the B. burgdorferi flagelline A (flaA) or 
flagelline B (flaB) promoter with the kanamycin-resistance gene from Tn903 (Bono et al., 
2000).  This strategy of linking flaB gene promoter to the selectable markers is now an 
established technique to genetically manipulate B. burgdorferi and routinely used by 
several laboratories.  Additional selectable markers have now been developed including 
ermC (conferring resistance to erythromycin) (Sartakova et al., 2000), aacC1 
(gentamycin) (Elias et al., 2002b), aadA (spectinomycin and streptomycin) (Frank et al., 
2003). 
The next confront is to delete genes in infectious B. burgdorferi.  Apparently, low 
passage, infectious B. burgdorferi isolates grow  slowly, exhibit lower plating efficiency 
and transformation frequencies are 100-fold lower than those of high passage, non-
infectious isolates (Tilly et al., 2000).  Amongst B. burgdorferi isolates, genetic 
manipulation studies often use the sequenced prototype isolate B31 and 297 whereas 
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some other isolates, such as N40 is relatively difficult to transform.  Interestingly, just as 
the loss of plasmids lp25, lp28-1, and lp28-4 correlates with loss of infectivity of B. 
burgdorferi, the absence of lp25 correlates with an increase in transformation efficiency. 
The lower transformation frequency is coupled with restriction-modification system in 
infectious B. burgdorferi which is encoded on the lp25 and lp56 plasmids and is missing 
or non-functional in in vitro cultivated B. burgdorferi (Lawrenz et al., 2002).  
Additionally, the nicotinamidase gene pncA (BBE02) positioned on lp25, also potentially 
effects transformation efficiency of B. burgdorferi.  Deletion of BBE02 increased the 
transformation efficiency for infectious B. burgdorferi B31, providing a valuable tool for 
determining virulence factors contributing to Lyme disease (Kawabata et al., 2004). 
Genetic complementation based on the use of shuttle vectors for trans-
complementation and vectors for cis-complementation has been developed for B. 
burgdorferi.  The first shuttle vector introduced in B. burgdorferi was pGK12 with an 
ermC gene conferring resistance to erythromycin (Sartakova et al., 2000).  Another 
vector, pBSV2 including a region of B. burgdorferi cp9 and a kanamycin resistance 
marker, was successfully transformed in low passage B. burgdorferi N40 (Stewart et al., 
2001) and served as the basis for the most widely used shuttle vector pBSV2G, 
containing a gentamicin resistance (GmR) marker (Elias et al., 2003).  Additional shuttle 
vectors and other complementation techniques for B. burgdorferi are also available 
(Eggers et al., 2002; Hubner et al., 2001; Pal et al., 2008b; Promnares et al., 2009; 




1.5 Role of outer membrane proteins in B. burgdorferi infectivity and 
transmission 
 
Outer surface protein (Osp) A, OspB and OspC are amongst the first known 
borrelial proteins and are considered as the most abundant lipoprotein expressed by B. 
burgdorferi.  An OspA/B gene is organized under a single operon and is so far the most 
extensively studied lipoprotein (Barbour, 1988; Bergstrom et al., 1989).  OspC which is 
encoded on cp26 (Fraser et al., 1997b)  is homologous to variable small proteins (Vsps) 
of relapsing fever Borrelia (Carter et al., 1994). The expression of OspA/B and OspC are 
reciprocally regulated, undergoing a switch during Borrelia transition from its tick vector 
to the mammalian host.  In unfed ticks, B. burgdorferi express high amounts of OspA and 
OspB and almost undetectable levels of OspC, whereas during the blood meal and upon 
mammalian infection, OspA/B synthesis is down-regulated and OspC production is up-
regulated (de Silva AM, 1996; Schwan et al., 1995).  Immunization with OspA confers 
protective immunity and protects the host against subsequent B. burgdorferi infection 
(Wallich et al., 1996).  However, use of OspA as a vaccine is questionable because of 
possible side effects (Lathrop et al., 2002) amongst other reasons.  OspA may function as 
an adhesin in the tick midgut epithelium (Pal et al., 2001; Pal et al., 2004b)  and binds to 
tick gut receptor TROSPA (Pal et al., 2000; Pal et al., 2004a).  OspA  was also shown to 
bind to plasminogen (Coleman et al., 1997) and may provide protection for other surface 
proteins, such as P66, by shielding against possible protease digestion (Bunikis and 
Barbour, 1999).  OspC might facilitate the invasion of B. burgdorferi in tick salivary 
glands (Fingerle et al., 2007; Gilmore and Mbow, 1999; Pal et al., 2004b).  OspC binds to  
tick salivary protein Salp15 (Ramamoorthi et al., 2005), and OspC-Salp15 interaction 
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facilitates establishment of spirochete infection of the host and movement to the 
mammalian host (Gilmore and Mbow, 1999; Pal et al., 2004b).  In addition, OspC 
synthesis correlates with migration from the tick midgut to the salivary gland (Fingerle et 
al., 2002; Gilmore and Mbow, 1999; Leuba-Garcia, 1998; Schwan and Piesman, 2000).  
However, in another study B. burgdorferi OspC function was shown to be strictly 
required to infect mice, but did not seem to be necessary for spirochete dissemination to 
the salivary gland (Grimm et al., 2004a).   
The multicopy lipoproteins (Mlp) family is one of many paralog protein families 
and there are upto ten mlp genes which are differentially expressed in response to in vitro 
culture and host-induced environment, encoded on cp32 and cp18 plasmid (Caimano et 
al., 2000; Porcella et al., 1996).  Thus, Mlp expression is differentially up-regulated in 
harmony due to either elevated temperature (37°C versus 23°C), increased spirochete cell 
density, reduced pH (6.8 versus 8.0) of the culture medium, and by unknown host factors 
(Ojaimi et al., 2003; Ojaimi et al., 2005; Porcella et al., 2000; Yang et al., 1999; Yang et 
al., 2003).  These references circuitously suggest that Mlp proteins might also be 
involved in B. burgdorferi infections of the mammalian host.  Lp6.6, a small lipoprotein 
encoded by bba62, is drastically down-regulated throughout mammalian infection and its 
function might be coupled with B. burgdorferi encountering the tick environment 
(Lahdenne et al., 1997).  Lp6.6 has recently been demonstrated to facilitate transmission 
from tick to mice and is involved in maintaining stable protein complexes in the outer 
membrane (Promnares et al., 2009).  The RevA protein is expressed during mammalian 
infection, and is up-regulated immediately after the B. burgdorferi infected tick feeds on 
the mammal (Gilmore and Mbow, 1998; Gilmore et al., 2001).  Many more new B. 
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burgdorferi outer surface exposed lipoproteins have been identified  such as BB0323, 
BB0210, BB0329, BB0365, BB0668, BB0681, BB0844, BBA03, BBA07, BBA25, 
BBA34, BBA36, BBB19, BBI42, BBK07, BBK13, BBK32, BBK53, BBL40, BBM27, 
BBO40, BBP39, BBQ03 BB0689, BBA36, BBA66, and BBA69 that are actively 
expressed and immunogenic during B. burgdorferi  infections.  These membrane antigens 
can be targets of vaccine candidates to prevent the Lyme disease (Barbour et al., 2008; 
Brooks et al., 2006; Yang et al., 2009).  
The roles of outer membrane proteins as microbial adhesin have been studied in 
detail in B. burgdorferi.  A number of borrelial membrane antigens are identified that 
binds components of host extracellular matrix (ECM). The surface-exposed protein ErpX 
was identified as having affinity for laminin, and is the first laminin-binding protein to be 
identified in a Lyme disease spirochete (Brissette et al., 2009).  An additional B. 
burgdorferi protein that binds specific ECM molecules are the surface lipoprotein 
decorin-binding proteins A and B (DbpA/B) (Guo et al., 1998; Guo et al., 1995; Hanson 
et al., 1998), which is hypothesized to be involved in tissue tropism of Lyme disease 
spirochetes.  Expressions of these two proteins are temperature-regulated and are induced 
at 35°C rather than 23°C (Ojaimi et al., 2003).  Antibodies against DbpA can thwart an 
infection (Hagman et al., 1998; Hanson et al., 1998), which shows the importance of 
tissue adhesion in the pathogenesis of Lyme disease.  
Borrelia glycosaminoglycan-binding protein (Bgp) is a surface hemagglutinin of 
B. burgdorferi  andcan bind to heparan sulphate and dermatan sulphate.  Although, its 
classification as a lipoprotein is undetermined (Parveen and Leong, 2000), the adaptation 
of spirochetes to the mammalian host environment leads to enhanced glycosaminoglycan 
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(GAG) binding, thus playing a significant role during mammalian infection (Parveen N, 
2003).  Moreover, Bgp expression was up-regulated during conditions that mimicked tick 
feeding (Ramamoorthy and Philipp, 1998).  Secretion of Bgp into extracellular 
environment has always been noticed signifying a possible role as an immune response 
decoy (Cluss et al., 2004).  Bgp is a rare example of borrelial proteins that are known to 
be secreted into the extracellular milieu. 
 BBA64, BBK32, VlsE, OspC and BmpA, OM proteins are important diagnostic 
tools for early Lyme disease, being recognized by sera from B. burgdorferi infection and 
are also expressed in vivo and up-regulated at 35°C versus 23°C (Bryksin et al., 2005; 
Fikrig et al., 2000; Indest and Philipp, 2000; Magnarelli et al., 2002; Ojaimi et al., 2003).  
More recently, another OM protein BBK07 has been characterized as a novel 
serodiagnostic marker for Lyme disease (Barbour et al., 2008; Coleman and Pal, 2009).  
Although these OM proteins are induced during mammalian infection, in most cases their 
functions remain as an enigma.  However, BBK32 binds fibronectin (Probert and 
Johnson, 1998) and promotes B. burgdorferi attachment to GAGs (Fischer et al., 2006).  
Furthermore, inactivation of bbk32 in low-passage, infectious B. burgdorferi leads to 
significant attenuation of borrelial virulence in the mouse model of infection (Seshu et 
al., 2006).  Thus, the borrelial fibronectin-BBK32 interaction appears to be an important 
pathogenic mechanism of B. burgdorferi, particularly for dissemination and persistence 
(Norman et al., 2008; Seshu et al., 2006).  In contrast, another study concluded that 




Many lipoproteins have also been studied for being involved in serum resistance.  
OspE and OspF are the predominant members of OspE/F related proteins (Erp) encoded 
on both cp32 and cp18 plasmids.  B. burgdorferi can carry as many as nine different erp 
loci per cell and all can be expressed simultaneously (Akins et al., 1999; Casjens et al., 
2000a; Casjens et al., 1997; Stevenson et al., 1998; Stevenson et al., 1996).  Many Erps 
can bind complement inhibitory factor H helping B. burgdorferi to circumvent host-
mediated serum killing (Hellwage et al., 2001; Stevenson et al., 2002).  Fascinatingly, 
another group of lipoproteins possess OspE/F-like leader peptides (Elp).  Even though 
they are unrelated to OspE/F, few of them are transcriptionally associated (Akins et al., 
1999; Hefty et al., 2001).  Gene rearrangements within the Erp/Elp paralog families have 
contributed in sequence assortment, nurturing the parasitic strategy and immuno-
evasiveness of the Lyme disease pathogen (Akins et al., 1999; Caimano et al., 2000).  
Members of Erp and Elp families are differentially expressed during B. burgdorferi 
movement in tick and transmission to mammalian host (Akins et al., 1995; Hefty et al., 
2001; Stevenson et al., 1998).  Host-specific signals were found to alter the expression 
patterns and cellular localization of these lipoproteins (Hefty et al., 2002).   
B. burgdorferi is known to express up to 5 complement regulator-acquiring 
surface proteins (CRASPs).  CRASP-1 is a multifunctional protein of B. burgdorferi that 
binds to several human extracellular matrix proteins and plasminogen (Hallstrom et al., 
2010).  These interactions may contribute to organ tropism, bacterial colonization, 
adhesion and spreading of B. burgdorferi in the host.  CRASPs of B. afzelii also bind 
complement inhibitory factor H and factor H-like protein to avoid complement activation 
(Kraiczy et al., 2001), although a recent study demonstrated that the inactivation of one 
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of the factor H binding borrelial protein, BbCRASP-2, had insignificant effects on 
borrelial infectivity (Coleman et al., 2008).  Different strains of B. burgdorferi can be 
classified as  as sensitive, intermediate-sensitive or  resistant to the bactericidal effects of 
human serum (Kraiczy et al., 2001), which might associate with heterologous function 
CRASPs and OspE.  
In conclusion, a set of borrelial genes are identified that play important role in 
supporting spirochete persistence in the mammalian host or  arthropod vector or their 
transitions, such as ospC, rpoS, rpoN, rrp2, vlsE, bb0210, dbpBA, ospA, bptA, napA/dps, 
bba62, bb0690 and bb0365 (Caimano et al., 2007; Fisher et al., 2005; Grimm et al., 
2004b; Li et al., 2007b; Pal et al., 2008a; Pal et al., 2004b; Promnares et al., 2009; Revel 
et al., 2005; Shi et al., 2008; Weening et al., 2008; Yang et al., 2009; Yang et al., 2003; 
Yang et al., 2005; Yang et al., 2004).  These studies lend further support to the 
speculation that B. burgdorferi modifies its gene expression in a coordinated manner to 
adapt to different microenvironment(s) of hosts and the vector. 
1.6 Hypothesis 
 
  An experimental reproduction of infectious cycle of B. burgdorferi in the 
laboratory using mouse model has enabled us to carefully analyze the timing and 
mechanics of spirochete transmission from the tick to mouse (Piesman, 1993, 1995; 
Piesman et al., 1987; Piesman et al., 1990; Ribeiro et al., 1987).   However, literature 
search suggests that till date most of the investigations for understanding B. burgdorferi 
gene expression in vivo or virulence have been focused on the mammalian side.  
Although OspA has been approved by FDA for human use as a Lyme disease vaccine, it 
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was withdrawn from the market within two years of FDA approval, due to several 
reasons including poor sales by the manufacturer, possible autoimmune disorder and 
relatively rapid waning of OspA antibody titer in vaccinated individuals.  Therefore, 
identification of novel vaccine candidate and development of new preventive measures 
remains a primary focus of Lyme disease research.  Here I employed high throughput 
quantititive reverse transcriptase PCR (qRT-PCR) method to study expression of novel 
membrane proteins of B. burgdorferi in ticks.  I optimized a high-throughput qRT-PCR 
based assay to compare borrelial sub-genomic transcriptome between feeding ticks and 
murine hosts to identify genes that are primarily expressed in the arthropod vector.  I 
focused on the study of B. burgdorferi membrane antigens that are encoded by stable and 
conserved genetic elements.  In this dissertation I solely focused on a B. burgdorferi 
protein BBA52, which is expressed in ticks but is not produced during mammalian 
infection.  Infact, I discovered that BBA52 is a vector-specific and feeding-induced gene 
product that is also highly immunogenic.  I hypothesized that B. burgdorferi OM 
proteins, if found to be critical for borrelial persistence and transmission between ticks 
and mammalian hosts, could be used as a novel antigenic target to develop new 









Chapter 2: Analysis of B. burgdorferi transcriptome during 
pathogen transmission from feeding ticks to naïve hosts 
 
Abstract 
B. burgdorferi, the pathogen of Lyme borreliosis, persists in a natural tick-rodent 
transmission cycle.  Assessment of in vivo and in vitro microbial transcriptome encoding 
selected membrane proteins by high throughput qRT-PCR, showed bba62, bba52, 
bb0323, bba74, bbe31, bbg01  are predominantly expressed during vector-specific phase 
of B. burgdorferi life cycle  compared to mammalian host.  In addition, bba52 and bba62 
are expressed exclusively in vector, and have no detectable expression in the mammalian 
host.  Further assessment of these proteins may shed new light on vector-pathogen 
interaction and B. burgdorferi persistence through a tick-rodent cycle. 
 
2.1 Introduction  
 
B. burgdorferi is unique spirochete which requires obligate blood-feeding 
arthropods for the transmission and maintenance in susceptible vertebrate host 
populations (Canale-Parola, 1984). The four principal hard tick species from the family 
Ixodidae that transmit Lyme disease spirochetes (Borrelia burgdorferi sensu lato) include 
Ixodes scapularis in eastern North America, I. pacificus in western North America, I. 
persulcatus in Asia, and I. ricinus in Europe.  B. burgdorferi does not readily infect most 
tick, suggesting that the interactions between Ixodes are highly specific.  A few past 
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studies have shed light on the pathogen-vector interaction (de Silva AM, 2009; Fikrig and 
Narasimhan, 2006; Munderloh and Kurtti, 1995; Tsao, 2009).  The first report of a 
functional genomics approach to assess differential expression of B. burgdorferi genes 
cultivated in different environments involved a microarray based analysis (Revel et al., 
2002a).   Subsequently other studies also described transcriptional profiles of B. 
burgdorferi genes regulated either by temperature (Ojaimi et al., 2003)  or mammalian 
host factors including spirochete cultivation in dialysis membrane chamber (DMC) 
implanted under the host skin or exposure of cultured B. burgdorferi to blood (Brooks et 
al., 2003; Tokarz et al., 2004).  Along with microarray, other tool like DECAL 
(differential expression with a customized amplification library) has been used to 
understand transcriptome of B. burgdorferi in fed tick (Narasimhan et al., 2002b; Pal et 
al., 2008a).  However, the host environments are likely to be too complex to be 
reproduced in vitro.  Therefore, genes that are expressed in vivo, especially in the vector 
are required for a better understanding of B. burgdorferi infection cycle.  In fact 
identification of antigens that are expressed in the vector has important implication for 
identification of vaccines against tick-borne disease like Lyme disease.  As antigens 
expressed in the host are, often, not effective vaccine candidates because pathogen evolve 
defensive mechanisms to evade the sophisticated immune system of mammals, including 
antigen variation via variable recombination and differential gene expression (De Silva 
and Fikrig, 1997; Zhang et al., 1997; Zhang and Norris, 1998).  On the other hand, the 
vector lacks an adaptive immune system, the antigenic variation mechanisms of B. 
burgdorferi appear to be minimally active (Indest et al., 2001; Nosbisch and de Silva, 
2007) and the antigens expressed by B. burgdorferi are primarily conserved in vector.  
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Here in this chapter, I have optimized and employed a high throughput quantitative 
reverse transcriptase PCR (qRT-PCR) analyses to measure the B. burgdorferi gene 
expression in feeding ticks and compared it with corresponding gene expression in 
spirochetes that are either in vitro grown or isolated from derimis of infected mice.  I was 
interested to identify the B. burgdorferi gene products that are exclusively expressed in 
ticks during the enzootic infection cycle of spirochetes.  Further identification of B. 
burgdorferi antigens that are essential for spirochete persistence and transmission through 
the vector could potentially contribute to the development of a transmission-blocking 
vaccine. 
2.1.1 Differential expression of Borrelia burgdorferi transcriptome in mammalian 
host and tick vector 
 B. burgdorferi has evolved strategies to differentially express its gene products 
including surface antigens that likely plays important role in pathogen survival in two 
significantly different niches of rodent host and arthropod vectors.  Mammals and tick 
possess radically different microenvironment for B. burgdorferi in terms of immune 
system, nutrient content, oxidative state, pH and temperature amongst other factors.  
Being unique in its genome content among all other bacterium, B. burgdorferi is able to 
maintain a segmented genome with 21 extra chromosomal plasmids and regulate genes in 
a tight temporal and spatial pattern in order to sustain itself in the enzootic cycle.  This 
differential expression of B. burgdorferi has been a special interest by the researcher 
community to exploit these genes that are induced at a given time and tissue location, and 




The recent advancement in the molecular techniques for manipulating B. 
burgdorferi genome has helped scientists to identify many conundrums of spirochetal 
infection in human and animal populations.  Techniques like microarray, DECAL and 
quantitative PCR analysis have proved to be central tools to identify the catalog of B. 
burgdorferi differentially expressed genes during the pathogen persistence in the 
mammals or in ticks.  B. burgdorferi has developed strategies to survive in two different 
niches by orchestrating the expression of various genes in response to the changing 
environment (Pal and Fikrig, 2003).  As example, B. burgdorferi synthesizes fibronectin-
binding protein (BBK32), decorin-binding protein (DbpA), a family of anticomplement 
proteins (Erp‟s), and VlsE proteins in mammals, and these proteins facilitate spirochete 
dissemination and survival within the mammal (Barthold et al., 1990; Fikrig et al., 2000; 
Guo et al., 1998).  In contrast, outer surface protein A (OspA) and OspB are expressed 
mainly by B. burgdorferi in ticks (Li et al., 2007b; Schwan and Piesman, 2000).  BB0690 
is highly expressed in B. burgdorferi residing in the gut of the quiescent intermolt I. 
scapularis and likely plays a role in protecting spirochetes during dormancy in unfed 
ticks (Li et al., 2007b). 
A variety of animal models have been identified to study B. burgdorferi infection. 
Amongst these models, murine models are most popular; in particular C3H/He mice are 
most widely used.  Inbred C3H/He mice can readily be infected with B. burgdorferi via 
needle challenge or tick feeding (Anguita et al., 2003; Barthold et al., 1990; Barthold et 
al., 1993).  The spirochete disseminates to various murine tissues like skin, heart, joint, 
bladder and cause severe arthritis and carditis.  Similarly, analysis of B. burgdorferi 
transcriptome in I. scapularis during feeding on B. burgdorferi-infected mice provides 
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evidence for their survival strategies in the vector.  During the first blood meal of larval 
ticks on infected mice, the bacterium first enters the gut of the tick and resides in the gut 
throughout the long intermolt periods of low metabolic activity (Pal and Fikrig, 2003).  
The spirochete exits the gut during subsequent blood meal, passes to salivary gland and is 
transmitted to vertebrate host (Fikrig and Narasimhan, 2006).  During the entire voyage 
in ticks, B. burgdorferi undergoes marked changes in the expression of surface proteins 
for its successful transmission to another vertebrate host. 
Recent studies have identified a number of B. burgdorferi genes that are 
upregulated in the vector which plays significant role in survival of spirochete in ticks 
(Munderloh and Kurtti, 2005).  As example, ospA and ospB genes facilitate B. 
burgdorferi colonization in tick gut (Neelakanta et al., 2007; Pal et al., 2001; Yang et al., 
2004).  Similarly, ospC is involved in the transmission of B. burgdorferi through ticks 
(Pal et al., 2004b) and establishment of infection in the mammalian host (Grimm et al., 
2004b).  Additional gene expression profile has been studied in arthropod vector and 
includes erpT (Fikrig et al., 1999), bbk32 and bbk50 (Fikrig et al., 2000), rev, mlpA, 
erpa/i/n, and erpb/j/o (Gilmore et al., 2001), bb0690 (Li et al., 2007b).  Although some 
genes are dramatically and specifically upregulated in B. burgdorferi life cycle, gene 
deletion studies suggested they are functionally redundant and does not play critical role 
in pathogen persistence and transmission (Coleman et al., 2008; Hubner et al., 2003; Li et 
al., 2007a; Stewart et al., 2008).   
 




 2.2.1 Oligonucleotide synthesis of hypothetical genes of B. burgdorferi  
About 140 genes were selected based on their predicted localization to the 
spirochete membrane, according to the database annotation, and PSORT prediction in 
silico analysis (Yang et al., 2009).  The primers used for qRT-PCR reaction was designed 
using OligoPerfect Primer design software (Invitrogen) based on the B. burgdorferi B31 
M1 genomic sequence (Casjens et al., 2000a; Fraser et al., 1997b).  All qRT-PCR primer 
pairs with a similar annealing temperature (60ºC) and an amplicon size ranging from 100-
300 base pairs were designed for each of the selected B. burgdorferi genes.  Each primer 
pair was tested for efficiency and non-specific amplification by melt-curve analysis using 
B. burgdorferi genomic DNA as a template in the iQ5 real-time thermal cycler using 
iQ
TM
 SYBR Green Supermix according to the manufacturer‟s instruction (Bio-Rad 
laboratories) (Livak and Schmittgen, 2001). 
 
2.2.2 Laboratory infection of the Ixodes tick with B31A3 infectious strain of Borrelia 
   A group of five C3H mice was infected with B. burgdorferi intradermally (10
5 
spirochete/animal) by needle inoculation.  For this, B. burgdorferi B31A3 (Elias et al., 
2002b) strain was grown at 34°C incubator in the laboratory prepared BSK medium by 
reculturing from the glycerol stock of B. burgdorferi.  After four to five days of culture, 
the concentration of B. burgdorferi was counted on a Petroff Hausser Counting Chamber 
under a dark field microscope.  The number of bacteria per ml was calculated by counting 
the four outside corners of the central square millimeter and by multiplying the average 
of the four corners count by 16×5×10
4
.  If the culture is collected from the late log or 
stationary growth phase with higher concentration of bacteria, the culture can be diluted 
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in sterile PBS or BSK in 1:10 for more accurate counting by the microscope.  Once the 
counting was done, mice were restrained appropriately and the injection site was cleaned 
with 70% ethanol.  Using 1 ml tuberculin syringe with 25 G needle, mice were injected a 
single injection intradermally 10
5
 spirochetes in 100-200 µl of BSK media for each 
animal.  For feeding studies, unfed larvae were obtained from our collaborator in 
Connecticut Agriculture Experiment Station.  After 14 days of infection, 30-40 Ixodes 
larvae were fed on each C3H mouse separately.  For set up of tick feeding, the mice was 
first anaesthetized using Ketamine and Xylazine combination (Ketamine: 120 mg/Kg and 
Xylazine: 16 mg/Kg) and the dose rate was 0.1 ml/10g body weight intraperitoneally.  
The cage containing the unconscious mice were placed on a sticky mat (Adhesive 
entryway, Fisherbrand
®
) to avoid possible escape of larvae.  Mice were infested with 
larvae by gentle brushing with a light paint brush.  Mice were allowed to regain its 
consciousness and in the mean time, mice cage box were prepared.  The mice cage 
contains dry raised wire mesh that holded mice comfortably and underneath which, there 
was water to collect larvae after repletion.  There was an additional barrier to prevent 
accidental escapes of larvae- entire mouse cage was placed within a larger rabbit cage 
with a thin layer of contained water. The whole mouse cage setup was then allowed to 
stand over 2.5×2.5 feet sticky mat (Adhesive entryway, Fisherbrand
®
) placed on the 
racks.  It is mandatory to keep one mice per cage as they have social instinct to remove 
larvae from each other.  After repletion, the ticks were collected as fed B. burgdorferi-
infected larvae.  The larvae were stored in a properly humidified chamber, maintained at 
25°C after being received.  I used a commercially-available environmental chamber that 
was set at 24°C with 16h/8h light/dark photoperiod regimen and 95% humidity.  In this 
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condition, fed larvae usually molt to nymphs within 4-5 weeks following engorgement.  
This group of newly molted infected ticks could be used for laboratory transmission of B. 
burgdorferi to the naïve mice.  B. burgdorferi infectivity in the molted ticks was tested by 
qRT-PCR using flaB gene primer, a housekeeping gene of the B. burgdorferi for one of 
the flagellar proteins. 
 
2.2.3  Experimental infection of naïve mice with the infected Ixodes Nymph and 
comparative expression analysis of B. burgdorferi gene in the vector, host and in 
vitro culture using quantitative RT-PCR. 
After molting of the infected larvae to nymph, a group of 5 mice was fed with 10 
infected nymphs separately on each mouse with the same cage settings as discussed 
before with the larvae feeding.  Five ticks was collected forcefully at different time point 
from the mice after 24 h, 48 h and 96 h of transmission using fine forceps and stored in 
liquid nitrogen until RNA was extracted.  Simultaneously, mice was sacrificed after two 
weeks of B. burgdorferi infected tick infestation by atlanto-occipital joint dislocation and 
mice tissue skin, heart, joint (ankle) and bladder were collected under sterile condition 
and stored in liquid nitrogen until RNA extraction.  RNA was extracted from the tick 
sample using the Qiagen RNA extraction kit followed by DNase treatment (NEB).  
cDNA synthesis was performed using Stratagene cDNA synthesis kit using random 
primer as per the protocol.  For the mice tissue, RNA was extracted after homogenizing 
the tissue sample in liquid nitrogen using pestle and mortar.  The RNA extraction was 
performed using the Trizol reagent (Invitrogen).  Briefly, pooled tissues were 
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homogenized by crystallizing the samples using liquid nitrogen in pestle and mortar.  
Tissues were homogenized in 1 ml of Trizol reagent per 50-100 mg of tissue using pestle 
and mortar.  The homogenized samples were incubated at room temperature for 5 min to 
permit complete dissociation of nucleoprotein complexes.  Thereafter, 0.2 ml of 
chloroform per ml of Trizol was added in the Eppendorf tube and was vigorously shaken 
for 15 sec and incubated at room temperature for 5 min followed by centrifugation at 
12000×g for 15 min at 4°C.  Following centrifugation, the aqueous phase was separated 
carefully in another Eppendorf tube and RNA was precipitated with 0.5 ml of 
Isopropanol for 10 min at room temperature and then centrifuged for 10 min at 12000×g 
at 4°C.  The RNA pellet obtained was washed with 1 ml of 75% ethanol per 1 ml Trizol.  
RNA obtained was further treated with DNase.  Briefly, about 10 µg RNA was treated 
with 2 units of DNase in a 20 µl reaction at 37°C for 10 min followed by heat 
inactivation of DNase at 75°C for 10 min after adding 5 mM final concentration EDTA.  
First strand cDNA synthesis was performed from these tissues RNA using Stratagene 
cDNA synthesis kit as follows.  About 2 µg of RNA in 15.7 µl of water and 3 µl of 
random primer (0.1 µg /µl) was incubated together at 65°C for 5 min followed by 25°C 
for 10 min.  Thereafter, a mastermix consisting of 2 µl of 10×AffinityScript RT buffer, 
0.8 µl of dNTP mix (25 mM each dNTP), 0.5 µl of RNase Block Ribonuclease Inhibitor 
(40 U/µl) and 1 µl of Affinity Script Multiple Temperature Reverse Transcriptase was 
prepared.  A total of 20 µl of final reaction volume was prepared and the reaction was set 
up at 25°C for 10 min, 42°C for 60 min followed by termination of the reaction at 70°C 
for 15 min and then to 4°C. 
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At the same time, another group of five mice was challenged with single 
intradermal injection with 10
5
 spirochetes/mouse.  At day fourteen of infection, mice 
were sacrificed by atlanto-occipital joint dislocation for RNA extraction from skin 
sample.  For isolation of RNA from in vitro grown cells, B. burgdorferi were grown in 
BSK medium at 34°C to a concentration of 10
8
 per ml.  RNA was extracted by Trizol 
reagent from 10
8
 cells, followed by DNase treatment and first strand cDNA synthesis as 
discussed before.  A sensitive quantitative RT-PCR (qRT-PCR) approach was used to 
compare spirochete transcriptomes in tick tissues, mice skin and in vitro grown B. 
burgdorferi in BSK medium. The primers used for the qRT-PCR reaction were designed 
using OligoPerfect Primer design software (Invitrogen) with the same annealing 
temperature (60°C) and a similar amplicon size (~200 bp), using the B. burgdorferi B31 
M1 genomic sequence.  To further ensure specific amplification of B. burgdorferi cDNA 
in tissue samples, thermal cycling in each well was followed by melt-curve analysis, and 
wells showing non-specific amplification were discarded from the data analysis.  For 
expression screening of B. burgdorferi genes, I simultaneously assayed several candidate 
genes in a 96-well PCR plate, using duplicate wells of  template cDNA ( cultured 
spirochetes, infected skin and tick samples) with parallel positive  (B. burgdorferi 
genomic DNA) and negative (no template) controls.  Transcripts levels of individual gene 
in murine and tick samples were calculated using the 2
-ΔΔCt
 method (Livak and 
Schmittgen, 2001) normalized against flaB transcripts and represented as gene expression 
levels relative to the flaB expression in corresponding tissues derived from two 
independent expreriments.  For measuring gene-specific transcripts of spirochete using 
qRT-PCR, tick cDNA of different time points was pooled together and fold increase in 
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the expression of individual genes in each of the murine, tick sample and in vitro grown 
Borrelia was calculated based on threshold cycle (Ct) values using the 2
-∆∆
Ct method, 
normalized against flaB Ct values (Yang et al., 2009).  The cyclic reaction condition that 
was used for quantifying the gene expression of Borrelia was as follows: 
Cycle 1×1         Step 1        95°C    3 min 
Cycle 2×50       Step 1        95°C   10 sec 
                          Step 2        60°C   20 sec 
                          Step 3        72°C   20 sec 
 
Briefly, qRT-PCR reaction was set  up in 20 µl reaction volume consisting of 10 µl of 
2×SYBR Green, 1 µl of primers (Forward and Reverse,10 µM),  8 µl of water, and 1 µl 
of cDNA. 
 
2.3 Results  
 
B. burgdorferi faces radically different tissue environments during host-vector 
transitions and presumably alters antigenic expression to complete the transition and 
persist in the new environment.  To identify microbial genes that are differentially 
expressed in feeding ticks during transmission, the transcript levels of selected spirochete 
genes in nymphs and murine dermis were compared using qRT-PCR analysis.  The genes 
were selected because of their putative membrane localization, as determined by database 
annotation and in silico analysis for extracellular exposure.  Naive mice (5 
animals/group) were infested with B. burgdorferi–infected nymphs (25 ticks/group), and 
ticks were collected at 24–96 h of feeding and then pooled together.  Dermis samples 
were collected from groups of mice (5 animals/group) at 2 weeks after infection.  Both 
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murine and tick samples were subjected to qRT-PCR analysis performed as detailed in 
section 2.2.3.  The results are represented as the fold increase in individual gene 
transcript levels relative to flaB expression.  bba52, along with a few other B. burgdorferi 
genes, is highly expressed in feeding ticks during transmission, in comparison with its 
transcript levels in mice (FIGURE 1).  I choose to focus on bba52, on the basis of 
previous studies showing likely tick-specific expression (Ojaimi et al., 2003; Tokarz et 
al., 2004), its annotation as a nonparalogous and outer membrane protein of unknown 
function (Casjens et al., 2000a; Fraser et al., 1997b), and its unique genomic location as 
an insertion into the stable plasmid lp54, which otherwise contains many redundant 












































Figure 1. Relative expression levels of selected Borrelia burgdorferi genes in feeding ticks during transmission. 
 
Total RNA was isolated from cultured spirochetes; from pooled B. burgdorferi–infected nymphs collected at 24, 48, and 96 
h of feeding on naive mice; and from murine skin after 2 weeks of B. burgdorferi infection. Total RNA was converted to 
complementary DNA for measuring gene-specific transcripts by use of quantitative reverse-transcription polymerase chain 
reaction (qRT-PCR). The fold increase in expression levels of individual genes in each of the tick or murine samples was 
calculated based on threshold cycle (Ct) values, by use of the 2
-ΔΔCt
 method and normalized against flaB Ct values. Upper, 
middle, and lower panels, genes with the highest, moderate, and lowest expression ratios, respectively, relative to that of 
flaB. Bars denote the mean±standard deviation from 4 qRT-PCR analyses of 2 independent infection experiments. Arrows 



















Sequence (5  3: Forward, Reverse) 
BB0019 CHP  CGACTTCCAGTGGCAATTTT, 
AATTTGCATTCATTCCGCTAT 
BB0027 CHP  CCGCAGCCAATATTGATAGG, 
TATTGCCCCAATACCTCCTG 
BB0028 
LP  ACATTGCAGCCATGCATTTA, 
TACGCCATCTCTTCCTACGG 
BB0108 BMP  TGGGAACTGTAGGGATTAGCTC, 
CCTTGCTTTGAAGCCTCTTG 




BB0155 LP  GGAACACTTCCTGGTGCAAT, 
TTTTTAAATCGGGGTTTGTTTT 
BB0213 LP  TGATTCTAGCCTTGGAAAGGA, 
TGCCCTTATCAAAAAGACGAA 
BB0258 
Undecaprenol kinase  TACCGGAGTTGTTGGGACTT, 
GCCCCATAAAAATTCCTGCT 
BB0262 










Exported protein  GCGAGTGGATAGAAATGCTTG, 
CAGCATTTCCAAAGCCAGAT 
BB0323 








Membrane protein, putative  TGCAAAAAGTTGTGGCCTTT, 
TTCGCTCTGCTCATTGTCTTT 





Trehalase  GTGGGCATGACCTTTAGAGC, 
GCAACGCTTCTACCAGCTTC 
BB0469 
lspA  TTTCTTGCAATGCCTATTTTCA, 
GGCCATCTATCAAGTCCAAAA 
BB0586 


















Rare lipoprotein A  CATGGTATGGCGAAGCTTTT, 
CTCAGCGGCATATTTTGACA 
BB0744 
Borrelia P83/P100 antigen  AAGCACTCAGCAAGGCATTC, 
GAAAATTTGGCCAATCTCCA 
BB0769 
Glycoprotease family  GCCTGAGATTGCCTCAAGAC, 
GTGCATTAAAGGGGCGTAAA 
BB0843 
Arginine-ornithine antiporter  TTGGTGGATGCAAGAAATGA, 
AACCTTTCACAAACGCATCC 
BBA03 
OMP,BbK2.14 (297)  GAAAAATCGCAAGCCAAATC, 
TTCGTCTCCACCGCTATTTT 
BBA33 
LP  CAGCGAGATTAAAGTTGGCAA, 
CTGGCTGTGGATCAAGAACA 
BBA52 
OMP  CCAAAAGCCCACAAGGTGTA, 
TCTCTTTCCCCATCATCTGG 
BBA62 
Lp6.6  TGTTGCTTGCGAAACTACAAG, 
TGTCTGGCATTGACTTCATCA 
BBA64 
P35 antigen 54 TAATGCCAACAATGCTCCAA, 
GTGGCTGTCAAAATGCACTG 
BBA73 
Putative antigen P35, LP 54 CGCAAACATCAAGCTCAAAC, 
CCGAGAATTTTTCCATCAGC 





LP  GGTGCATCTTTTAAGGCAGAA, 
TCCATCTTTACATTCGCCAAG 
BBE31 
Putative surface protein, LP 60 ATTTGGCACTTTTTGCAACC, 
TTCCGTTAAATGAGATTCAAGC 
BBG01 
LP 12 GACACCGCTCAGAAAAGGTT, 
TGCGTCACTTAAAGCCTGTC 
BBI16 
VraA 60 CTGTTTTAAGCCCCCTGGAT, 
GCTTTTCCTGCAACACTTCC 
BBJ23 
TPR repeat domain protein 106 TTATTCGGGCAAAATTGAGG, 
TCCTGCAAATATCGCTTTGA 
BBJ27 





CHP 65 GATTGGAATCAAATGAAACAAAAA, 
AACCTTTTAGTTGTAACAGGCACA 
BBK45 





blyA-8 109 TGATTTTTGTAACAGTGCTGGTTT, 
TGTGATTTTTGCCATTACCA 
BBM38 
Holin, BlyA family, erpK, LP 164 TGCAAGAATTACGCAAGTGG, 
TTCAGCAACACCTTGAACCA 
BBN26 
Orf D-9 143 AACCCGCCAATTATTCCAAC, 
CGCAGTTATGGAGTGTTCGT 
BBN38 
ErpP, LP 162 GTTTAAACGCTGGGGGACAT, 
ACGCAATATGTTCAGCACCA 
BBN39 
ErpQ, LP 163 GTGCTGTTTTTGCGCTGATA, 
TCGCCCTGCATTAATTCTTC 
 
Abbreviations: CHP, conserved hypothetical protein; HP, hypothetical protein; LP, lipoprotein; OMP, outer 
membrane protein; MSP, membrane-spanning protein.  Designations of the open reading frame (ORF), 







B. burgdorferi undergoes remarkable changes in antigenic composition as it 
invades and colonizes diverse tissues in arthropods and mammals (Fingerle et al., 2002; 
Liang et al., 2002b; Narasimhan et al., 2003; Narasimhan et al., 2002b; Schwan et al., 
1995; Tilly et al., 2008; Yang et al., 2009).  These changes are mediated at least in more 
than 10 percent of all B.burgdorferi genes by regulatory networks involving Rrp2-
RpoN/RpoS or Rrp1–Hpk1 TCS and c-di-GMP (Boardman et al., 2008; Caimano et al., 
2007; Hubner et al., 2001; Rogers et al., 2009a; Yang et al., 2003), in addition to the 
intergenic recombination-based mechanism involving the vlsE locus (Coutte et al., 2009; 
Zhang et al., 1997).  Microarray analyses of transcriptional alterations in cultured 
spirochetes identified a large number of genes that are differentially expressed, including 
bba52 which responded to physiochemical alterations, including variations in 
temperature, the addition of blood, or growth in a dialysis membrane chamber (DMC) 
implanted within the murine host (Brooks et al., 2003; Caimano et al., 2007; Ojaimi et 
al., 2003; Tokarz et al., 2004).  In agreement with these findings, my data show that 
selected B. burgdorferi genes are also variably expressed in vivo and highly transcribed in 
feeding ticks during transmission.  The expression pattern of many of these genes 
bb0323, bba52, bba62, bba74, and bbe31 agreed with previous studies of cultured 
spirochetes that predicted preferential expression in ticks (Brooks et al., 2003; Caimano 
et al., 2007; Ojaimi et al., 2002; Tokarz et al., 2004).  Specifically, bba74 (Mulay et al., 
2009) and bba62 (Promnares et al., 2009) were recently identified as being expressed in 
feeding ticks.  Another gene, bbg01  has been reported to be upregulated by several fold 
in B. burgdorferi  sensu stricto (designated N40 strain) by tick transmission after being 
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passaged for 75 times, showing possible role in pathogenesis (Adusumilli et al., 2010).  
The majority of these genes, however, encoded proteins of unknown functions that are 
possibly relevant for pathogen transmission from feeding ticks or for the establishment of 























Chapter 3: Characterization of a selected tick-induced target 
gene, bba52 for its role in pathogen persistence, pathogenesis 
and vector-host transitions 
 
Abstract 
B. burgdorferi, the pathogen of Lyme borreliosis, persists in nature through a tick-
rodent transmission cycle.  A selective assessment of the microbial transcriptome, limited 
to gene encoding putative membrane proteins, reveals that bba52 transcription in vivo is 
strictly confined to the vector-specific portion of microbial life cycle with highest 
expression levels in feeding ticks and swift downregulation in mice.  bba52 deletion did 
not affect murine disease as assessed by the genesis of arthritis and carditis or long-term 
pathogen persistence in mice or ticks.  However, bba52 deficiency did impair microbial 
transitions between hosts and vector, defects that could be fully rescued when bba52 
expression was genetically restored to the original genomic locus.  These studies 
establish that BBA52 facilitates vector-host transitions by the pathogen and as such, is a 








 Lyme borreliosis, caused by B. burgdorferi, is a vector-borne zoonosis prevalent 
in North America and Europe (Piesman and Eisen, 2008a, b).  When feeding on an 
infected host, immature Ixodes ticks acquire the pathogen and during a subsequent blood 
meal, transmit the pathogen to a new host.  Infected humans develop serious clinical 
complications including arthritis, carditis and a variety of neurological disorders (Steere 
et al., 2004).  As wild rodents are the natural reservoir hosts of B. burgdorferi, certain 
inbred mice, such as C3H mice are considered excellent models of pathogenesis and are 
use to study the transmission cycle of spirochetes (Barthold, 1992).  Genome sequencing 
of B. burgdorferi (Casjens et al., 2000b; Fraser et al., 1997a), studies on the expression 
and regulation of borrelial genes (Blevins et al., 2009; Brooks et al., 2003; Caimano et 
al., 2007; Fisher et al., 2005; He et al., 2008; Liang et al., 2002a; Narasimhan et al., 2003; 
Ojaimi et al., 2002; Revel et al., 2002b; Rogers et al., 2009b; Tokarz et al., 2004; Yang et 
al., 2003) and advances in genetic manipulation techniques (Rosa et al., 2005) have all 
greatly contributed to our understanding of the unique biology and enzootic infection 
cycle of this spirochete.  However, a human vaccine against B. burgdorferi is currently 
unavailable, and thus, the development of effective preventive measures remains one of 
the major focus of Lyme disease research.  
B. burgdorferi may persist in a host or vector for months to years, shuffling 
between locations during short episodes of tick feeding (de Silva et al., 2009).  During 
migration from an infected tick to a host, B. burgdorferi invades salivary glands and 
transmits along with tick saliva (de Silva et al., 2009).  Many salivary gland proteins 
(Salps) are feeding-induced, soluble and can influence the spirochete transition between 
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vector and host (Das et al., 2001; Rosa, 2005).  A few I. scapularis Salps have been 
identified (Narasimhan et al., 2007; Ramamoorthy et al., 2005; Tyson et al., 2007) that 
play important roles in spirochete infection cycle.  Further characterization of the 
interactions of Salps with borrelial antigens and their contributions to infectivity will aid 
in our understanding of poorly-understood aspects of borrelial transmission. 
It is clear that the identification of borrelial antigens that play important roles in 
spirochete survival in ticks or enable vector-host transitions is the key to blocking 
pathogen transmission.  As extracellularly exposed membrane proteins may directly 
interact with different environments during transmission or dissemination thus 
contributing to pathogen adaptation, I sought to assess the expression of selected putative 
membrane proteins in feeding ticks and mice.  I further studied one of these genes, 
bba52, which displayed vector-specific expression.  BBA52, annotated as an outer 
membrane protein of no assigned function (Casjens et al., 2000b; Fraser et al., 1997a), is 
encoded by the linear plasmid (lp) lp54, which is a stable extra-chromosomal element and 
is considered to be a necessary part of the spirochete genome (Terekhova et al., 2006).  I 
show that BBA52 facilitates vector-host transitions of B. burgdorferi and is a potential 
antigenic target to interfere with transmission of Lyme borreliosis. 
 
3.2 Materials and Methods 
 
 3.2.1 Animal and tick infection with B. burgdorferi 
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A group of five mice was infected with 10
5
 spirochete / mouse intradermally by 
needle inoculation.  After 14 days of infection, each mouse was infested with 10 naïve 
nymphs or 50 larvae.  Nymphs were collected after 66 h of feeding on mice while larvae 
were collected after complete feeding.  The samples were collected and stored in liquid 
nitrogen until RNA extraction.  For tick transmission, experiment was set up on a group 
of five mice.  Mice were anaesthetized using a combination ketamine and xylazine as 
described in section 2.2.2.  Once the mouse become unconscious, 10-20 B. burgdorferi 
infected ticks were allowed to parasitize on each mouse. The ticks were applied on mice 
using a fine paint brush.  At 42 h and 66 h of feeding, partially-fed ticks were forcefully 
removed from mice using fine forceps.  After collection from mice, ticks were 
immediately dissected under a high resolution dissecting microscope to separate the tick 
gut and salivary glands.  Dissection was accomplished by immersing the ticks under a 
drop of sterile PBS on a slide, which is necessary to prevent tick tissues from air drying.  
RNA was extracted from the dissected sample by Trizol as detailed in chapter 2 and 
following additional DNase treatment; the cDNA was synthesized using random 
hexamers.  
3.2.2 Generation of recombinant proteins and antisera 
3.2.2.1 Cloning of BBA52 open reading frame for protein expression in E.coli 
      A primer set for BBA52 ORF was designed with BamHI and XhoI restriction 
enzymes (Table 2) for directional cloning after deleting the signal peptide using B31 A3 
genome data base.  Genomic DNA of B. burgdorferi B31-A3 was isolated using the 
Qiagen DNA extraction kit for Gram negative bacteria as per the manufacturer‟s 
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protocol.  Using the B. burgdorferi genomic DNA, BBA52 without the sequence coding 
for signal peptide, was amplified by PCR at 58°C annealing temperature.  The BBA52 
PCR product was resolved using agarose gel electrophoresis and the amplicon purified 
from the excised gel slice using Qiagen gel purification kit as detailed in manufacturer‟s 
protocol.  About 1 µg of PGEX-6P-1 (Amersham-Pharmacia Biotech) vector and the 
insert, BBA52 amplicon was digested with restriction enzymes BamHI and XhoI (NEB) 
at 37°C for overnight.  Both the vector and the insert DNA fragments were again 
resolved using agarose gel electrophoresis and purified, as described above.  Ligation was 
performed for 2 h at room temperature in 10 µl reaction solutions consisting of 2 µl of 
vector, 6 µl of insert, 1µl of 10 × ligation buffers and 1 µl of DNA ligase (NEB).  Five µl 
of ligated product was used for transformation of chemically competent DH5α E.coli 
cells (Invitrogen).  The cells were removed from -70°C freezer, and after addition of 
ligated product, the cells were left on ice for 30 min.  Thereafter, the cells were quickly 
moved to 42°C water bath to provide a heat shock for 45 sec and immediately kept on ice 
for additional 10 min.  One ml of SOC medium was added and the transformed E. coli 
was kept for 1 h at 37°C on a shaking platform at 250 rpm.  After 1 h, 100 µl of 
transformed E. coli was plated on agar plate containing 100 µg /ml of ampicillin and left 
overnight at 37°C incubator.  Next day, about 10 clones were picked up from the agar 
plates to check for positive clones by colony PCR and were run for agarose gel 
electrophoresis.  Two of the positive clones selected by colony PCR were grown in 10 ml 
of LB medium for overnight and plasmid were extracted using Qiagen plasmid extraction 
kit as per the manufacturer‟s instruction.  One ml of each clone was cryopreserved in -
70°C in LB media containing 20% glycerol.  One microgram of the plasmid was used to 
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digest the insert using restriction enzymes BamHI and XhoI and resolved on the agarose 
gel electrophoresis to confirm the expected size of the cloned insert.  The plasmid clone 
was further sequenced to rule out any mutation during the DNA engineering.  To check 
the expression of BBA52 protein, the clone was grown overnight in LB media containing 
ampicillin and in the morning further diluted in 1:100 in fresh antibiotic-containing LB 
medium and grown until OD650 of 0.5.  The culture was then induced with 1mM IPTG for 
2 h. The cell lysates were run on a SDS-PAGE and stained with Coomassie brilliant blue 
for 1 h. The gel was then destained using the destaining solution for 1 h to visualize the 
overexpressed BBA52 in E.coli.  In the similar fashion another B. burgdorferi protein 
BBA62 was also cloned and produced in DH5α E.coli cells without the signal peptide, 
using primers as shown in Table 2. 
3.2.2.2 Overexpression and purification of GST-BBA52 and GST-BBA62 tagged 
protein 
E.coli clone expressing BBA52 and BBA62 was retrived from the glycerol stock 
and grown overnight in 10 ml LB medium containing ampicillin at 37°C shaking 
incubator.  Next morning, the culture was inoculated in two flasks each containing 500 
ml media and allowed to grow until the OD650 reached 0.5.  The expression of the protein 
of interest was induced by adding 1 mM IPTG for 2 h.  Thereafter, cells were centrifuged 
using Sorvall centrifug at 5000 rpm for 30 min. The pellets were treated with 20 ml of 
1% Triton-X-100 in PBS, left for 20 min on ice and then sonicated for 6 min under ice 
cold condition. The lysates were than centrifuged at 12000×g for 30 min at 4°C to 
remove the insoluble protein fraction.  In the mean time, about 700 µl of GST beads 
(Glutathione Sepharose™ 4B, GE healthcare) were added in the column and washed 
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twice with PBS to remove ethanol preservatives.  Finally, the column was equilibrated 
and plugged with stopper.  The clear supernatant after centrifugation was poured into the 
column and was allowed to bind with the beads for around 10-15 min.  The unbound 
protein was drained of the column and the beads were washed three times with PBS.  
Finally, the protein was eluted in Eppendorf tubes with Tris buffer pH 8.0 containing 10 
















Table 2: Oligonucleotide primers used in the current study 
 
Sequence     (5’ – 3’) Purpose 
GGGAGCTCA A A A G A C A A A A T C G C T T T G C  Primer P1, 5’ PCR of the left arm for constructing bba52 
mutant.  A SacI site (italicized) is attached for the purpose of 
cloning. 
AAGGATCCAATATTCTCCTAATATTTAGATGT Primer P2, 3’ PCR of the left arm for constructing bba52 
mutant.  A 
BamH1 (italicized) is attached for the purpose of cloning. 
GGGTCGACT G A T T T G C T T T G G A A G T T T T  Primer P3, 5’ PCR of the right arm for constructing bba52 
mutant.  A sal1 site (italicized) is attached for the purpose of 
cloning. 
GCGGTACCT T A A T C C T T T T G G C G A G TT  Primer P4, 3’PCR of the right arm for constructing bba52 
mutant.  A KpnI site (italicized) is attached for the purpose of 
cloning. 
GGTTGCATTCGATTCCTGTT Primer P5, upstream 5’ PCR primer for the detection of 
intended integration of pflaB-Kan cassette in bba52 locus 
AAGTAAAATCACCTCATCTTCTGCTGTT Primer P6, downstream 3’ PCR primer for the detection of 
intended integration of pflaB-Kan cassette in bba52 genomic 
locus 
 
AGTGTTGCAAGACCATTTGATTTTA Primer P7, bba52 forward primer 
TTAAATAAACTGATCTTCAAGAGAA Primer P8, bba52 reverse primer 
A T G A A T A A G C A A G A G A T T G C G A C Primer P9, kanamycin internal forward primer 
ATTCCGACTCGTCCAACATC  Primer P10, kanamycin internal reverse primer 
G T A A G C T C A G C C C G T G C A    Forward primer for RT-PCR of bba51 
G C T G T A A T A A A C C C C C A G A T T A A  Reverse primer for RT-PCR of bba51 
TGACGAAGAGATTGCAGTCAA  Forward primer for RT-PCR of bba53 
CTACCTTTGCTTTTTGGCTTT    Reverse primer for RT-PCR of bba53 
GCTCAAATAAGAGGTTTGTC Forward primer for RT-PCR of flaB 
ATTCCAAGCTCTTCAGCTG Reverse primer for RT-PCR of flaB 
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TTGCTGATCAAGCTCAATATAACCA Forward primer for Quantitative RT-PCR of flaB 
TTGAGACCCTGAAAGTGATGC Reverse primer for Quantitative RT-PCR of flaB 
AGAGGGAAATCGTGCGTGAC  Forward primer for Quantitative RT-PCR of mouse β-actin  
CAATAGTGATGACCTGGCCGT  Reverse primer for Quantitative RT-PCR of mouse β -actin 
GGTATCGTGCTCGACTC  Forward primer for Quantitative RT-PCR of tick β –actin 
ATCAGGTAGTCGGTCAGG  Reverse primer for Quantitative RT-PCR of tick β -actin 
CCAAAAGCCCACAAGGTGTA Forward primer for Quantitative RT-PCR of bba52 
TCTCTTTCCCCATCATCTGG Reverse primer for Quantitative RT-PCR of bba52 
CGGAATTCTTAAATAAACTGATCTTCAAGAG Primer P11, 3’ PCR of the left arm for constructing bba52 
complemented isolate.  A EcoRI site (italicized) is attached for 
cloning. 
CGGAATTCCGAGCTTCAAGGAAGA Primer P12, Forward primer for amplification of flgB-aadA 
cassette in pKFSS1 vector. A EcoRI site (italicized) is 
attached for cloning. 
CGCGGATCCATTATTTGCCGACTACC Primer P13, primer for amplification of flgB-aadA cassette in 




Forward primer for recombinant BBA52 production. A BamHI 
site (italicized) is attached for cloning. 
GGCTCGAGTTAAATAAACTGATCTTCAAGAG
AA 
Reverse primer for recombinant BBA52 production. A XhoI 
site (italicized) is attached for cloning. 
CGGGATCCATGCACCACCACCACCACCACA
GTGTTGCAAGACCATTTGATTTTA   
 Forward primer for recombinant BBA52 production with 6His-
tag at N-terminal in baculovirus. A BamHI site (italicized) is 
attached for cloning. 
CCGCTCGAGTTAAATAAACTGATCTTCAAGA
GAA  
Reverse primer for recombinant BBA52 production in 
baculovirus. A XhoI site (italicized) is attached for cloning. 
AAGGATCCGAAACTACAAGAATTTCAG Forward primer for recombinant BBA62. A BamHI site 
(italicized) is attached for cloning. 
AACTCGAGTTACTTTTTCATTGACTTTGT Reverse primer for recombinant BBA62.  A XhoI site 




3.2.2.3 Cloning of BBA52 open reading frame for protein expression in Baculovirus 
expression system 
A full-length BBA52 protein was made by using Bac-to-Bac expression system 
(Invitrogen).  Briefly as per manufacturer‟s protocol, a site-specific transposition of an 
expression cassette into a baculovirus shuttle vector (bacmid) is propagated in E. coli.  
The bacmid contains the low-copy-number mini-F replicon, a kanamycin resistance 
marker, and a segment of DNA encoding the lacZα peptide from a pUC-based cloning 
vector.  Inserted into the N-terminus of the lacZα gene is a short segment containing the 
attachment site for the bacterial transposon Tn7 (mini-attTn7) that does not disrupt the 
reading frame of the lacZα peptide.  The bacmid propagates in Escherichia coli 
DH10Bac™ as a large plasmid that confers resistance to kanamycin and can complement 
a lacZ deletion present on the chromosome to form colonies that are blue (Lac+) in the 
presence of a chromogenic substrate such as Bluo-gal or X-gal and the inducer IPTG.  
Recombinant bacmids (sometimes referred to as composite bacmids) are constructed by 
transposing a mini-Tn7 element from a pFastBac™ donor plasmid to the mini-attTn7 
attachment site on the bacmid when the Tn7 transposition functions are provided in trans 
by a helper plasmid. The helper plasmid confers resistance to tetracycline and encodes 
the transposase.  The mini-Tn7 in a pFastBac™ donor plasmid contains an expression 
cassette consisting of a Gm
r
 gene, a baculovirus-specific promoter, a multiple cloning 
site, and an SV40 poly(A) signal inserted between the left and right arms of Tn7.  The 
plasmid pFastBac™ was used to generate viruses which will express unfused 
recombinant proteins.  Genes to be expressed are inserted into the multiple cloning site of 
a pFastBac™ donor plasmid downstream of the baculovirus-specific promoter.  
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Insertions of the mini-Tn7 into the mini-attTn7 attachment site on the bacmid disrupts 
expression of the lacZα peptide, so colonies containing the recombinant bacmid are white 
in a background of blue colonies that harbor the unaltered bacmid.  Recombinant bacmid 
DNA can be rapidly isolated from small scale cultures and then used to transfect insect 
cells.   
Briefly, BBA52 ORF without the signal peptide sequence and with a 6×His tag at 
N-terminus was amplified  by PCR using two primers containing  BamH1 and Xho1 sites, 
and B. burgdorferi genomic DNA as template,  as shown in Table 2.  The amplicon was 
cloned into the pFastBac TOPO donor plasmid at BamHI and XhoI site.  The recombinant 
donor plasmid was transformed into competent DH10 Bac E.coli cells provided in the kit.  
E.coli containing the recombinant Bacmid (LacZ negative) was selected for obtaining 
pure miniprep of the recombinant Bacmid. The true recombination clone was further 
confirmed by doing PCR with M13/pUC forward and reverse primers, as described in the 
manufacturer‟s protocol.   
 
3.2.2.4 Sf9 cell culture, transfection and protein purification 
Vials containing Sf9 cells (commercially obtained from Invitrogen) were 
immediately stored in liquid nitrogen.  Sf-900
TM 
III SFM medium (GIBCO) was warmed 
to the room temperature.  In the mean time Sf9 cells were thawed at 37°C in water bath 
under sterile condition.  Immediately after thawing of cells, vial was sprayed with 70% 
ethanol to maintain the sterility.  About 2 ml of fresh Sf-900
TM 
III SFM medium was 
added to the cell and transferred to another tube containing 8 ml of Sf-900
TM 
III SFM 
medium.  Cells were pelleted at 1000 rpm for 5 minute and this washing step was 
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repeated twice.  Finally, cells were diluted with Sf-900
™ 
III SFM medium at a density of 
about 1-2×10
6
 cells per ml and are grown in tissue culture flasks in an incubator 
maintained at 27°C. 
One microgram of recombinant Bacmid containing BBA52 ORF was transfected 
to 8 ×10
5
 Sf9 cells in six well plate along with help of Cellfectin
®
 II reagent as per the 
standard protocol.  After 4 days, generation of recombinant virus was confirmed by 
western blot analysis with the Sf9 lysate obtained from the six-well plates and using anti-




 Sf9 cells were grown in spinner flasks and were infected with 40 ml of a high-titer 
recombinant
 
baculovirus stock in 500 ml of Sf-900
™ 
III SFM medium (GIBCO).  After 
96 h of
 
incubation at 27°C, the cells were harvested, and collected by centrifugation at 
2,000 rpm
 
(Sorvall FH18/250 rotor) for 5 min.  The cell pellet was resuspended in 
extraction buffer (50 mM Tris pH 8.0, 300 mM NaCl, 0.5% Triton X-100, 10 mM 
imidazole, 1 mM PMSF) and sonicated.  The lysates were clarified by centrifugation at 
20,000×g for 30 min.  The cell extract was incubated with Ni-NTA agarose resin 
(Invitrogen) for 2 h, then loaded into a column, washed with washing buffer (50 mM Tris 
pH 8.0, 300 mM NaCl, 0.5% TritonX-100, 40 mM imidazole), and the protein was eluted 
with PBS containing 1 M Imidazole, and stored at -70°C until further use. 
 
3.2.2.5 Generation of Murine and Rabbit antibody: 
Recombinant GST-tagged BBA62 and BBA52 along with recombinant N-
terminus 6×His tagged BBA52 proteins were used to generate antibodies in mice.  
Briefly, about 10 µg of each protein were separately used to immunize a group of mice (5 
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mice/group).  For primary immunization, antigen was prepared by making emulsions 
with equal amount of Freunds complete adjuvant (FCA) from Sigma.  About 200 µl of 
the emulsion containing about 10 µg of antigen was used to inject each mouse 
intradermally.  After 10 days, first booster was given with the same amount of antigen in 
each mouse using Freunds incomplete adjuvant (FIA).  Second booster was given in the 
next 10 days of first booster and in another 7 days of the second booster all mice were 
sacrificed for serum collection.  Serum titer was determined by ELISA with the BBA52 
coated plates. 
Polyclonal rabbit antibody against BBA52 was also produced commercially 
(Medicore, Inc.).  I also generated additional BBA52 antibodies against a carboxyl 
terminal peptide of the mature protein.  Using a commercial source (GenScript 
Corporation), affinity-purified polyclonal antibodies against a BBA52 peptide sequence 
(EFLDDPSQESDELEC) of predicted immunogenicity was generated in rabbits.  As a 
control, affinity purified IgGs were also isolated from normal rabbit serum.   
 
3.3 Construction of BBA52-pXLF10601 mutagenesis plasmid for target deletion of 
bba52 complete ORF of B. burgdorferi. 
3.3.1 Construction and Isolation of BBA52-pXLF10601 mutagenesis plasmid   
For B. burgdorferi gene manipulation, plasmid pXLF10601 was used to construct 
the mutagenesis plasmid as described (Coleman et al., 2008; Kumar et al., 2010; 
Promnares et al., 2009).  This plasmid harbors two multiple cloning sites (MCS1 and 
MCS2) flanking upstream and downstream of the kanamycin cassette driven by flaB 
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promoter of B. burgdorferi.  This plasmid also contains another ampicillin resistance 
cassette, required for selection in E. coli.  In order to create the mutagenic plasmid for 
creation of bba52 deficient  B. burgdorferi,  two sets of primers were designed  that 
encompass about 1500 bp, flanking upstream and downstream of BBA52.  The upstream 
and downstream of BBA52 gene was amplified by PCR and cloned at MCS1 and MCS2 
sites using the primers mentioned in Table 1.  P1 and P2 are the primers used to amplify 
the downstream flanking region of BBA52 gene and cloned at MCS1 site while P3 and 
P4 are the primers used to amplify upstream of BBA52 gene and cloned at MCS2 site.  
The construct was verified by sequencing of the insert and by digestion of the insert with 
the specific restriction endonuclease (NEB).  After confirmation of the desired construct, 
the recombinant plasmid was purified in larger quantities by using a maxiprep kit 
(Qiagen).  Finally, the plasmid was eluted in nuclease free water to a concentration of 4-5 
µg/µl. 
3.3.2 Preparation of competent B. burgdorferi: 
B. burgdorferi were grown in 100 ml of BSK medium at 34°C incubator until a 
density of  5×10
7
 cells/ml.  The cells were centrifuged in two 50 ml falcon tubes at 
4000×g for 20 min at 4°C.  Supernatants were decanted and the pellet obtained was 
resuspended in 12 ml of sterile chilled phosphate buffer saline (PBS) and finally 
centrifuged at 3000×g for 10 min at 4°C.  This step was repeated twice.  The pellet was 
resuspended again in filter sterilized 4 ml of chilled EPS (93 g/L sucrose, 15 %  glycerol) 
and centrifuged at  2000×g for 10 min at 4°C.  The supernatant obtained was decanted 
and the pellet was resuspended in 1.5 ml of EPS solution and centrifuged at 2000×g for 
10 min at room temperature.  Finally, the pellet was resuspended and equally distributed 
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in two 50 µl of chilled EPS aliquots.   About 25-30 µg of plasmid DNA was added to the 
resuspended pellet and electroporation was performed using 0.1 cm gap cuvette at 1.8 
KV, 25 µF, 400 Ω electroporation setup in an electroporator (BioRad).   After 
electroporation, B. bugdorferi cells were quickly recovered from the cuvette in a sterile 
condition, in 10 ml of BSK medium and left overnight at 34°C.  Next day, the 
transformed B. burgdorferi were placed on 96 well plates (Cellstar) after adding 10 ml of 
another fresh BSK medium with 350 µg /ml of kanamycin for the selection of 
transformants.  Plates were tightly sealed with plastic wrap and stored in humidified 
incubator maintained at 34°C.  After 10 day of incubation, each well was duplicated in 
another 96 well plate to replenish the kanamycin.  B. burgdorferi clones recovered after 
duplication, usually 5-7 days, were recultured in another 5 ml of BSK medium with 
kanamycin, and the generation of intended mutant was confirmed by immunoblot 
analysis against BBA52 protein, and also by PCR and RT-PCR analysis of DNA and 
cDNA, respectively isolated from each mutant clones.  Depending on the number of 
transformants that grow in selection medium, I usually assess 10-20 clones for further 
analysis. The endogenous set of plasmids contained in the parental B31A3 isolate was 
also assessed in the mutant isolates as described earlier (Zhang et al., 2009).  One of the 
bba52 mutant B. burgdorferi clones that retained the same set of plasmids as the wild 
type B. burgdorferi was selected for additional experiments.  Finally, to rule out, if 
targeted genetic manipulation of bba52 had exerted unwanted polar effect on the 
expression of immediately downstream gene, the expression of surrounding genes, such 
as bba51 as well bba53 was assessed by RT-PCR and qRT-PCR analysis. 
 3.3.3 Complementation of bba52 gene in the mutant B. burgdorferi  
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I implemented the similar protocol to transform bba52 mutant for 
complementation of bba52 gene as described before in section 3.3.2.  First, I constructed 
a shuttle plasmid pKFSS1 with bba52 native promoter for complementation in trans.  
Repeated attempts to transform spirochetes with this plasmid failed to generate a 
complemented isolate.  So, I next engineered a cis-construct in pXLF14301 with native 
bba52 promoter which complements the gene at chromosomal location between bb0445 
and bb446  gene as previously described (Zhang et al., 2009).  The native promoter of 
bba52 is undefined and there is a 40 bp intergenic region between the upstream gene 
bba51 and bba52.  When this 40 bp DNA element was used as a native promoter to drive 
expression of bba52 in the transformed spirochetes, I failed to obtain any complemented 
isolates.  Similary,  I further constructed both cis and trans constructs using pXLF14301 
and pKFSS1 plasmids, respectively where bba52 ORF is driven by the flaB promoter, 
however transformation with these new series of constructs failed to achieve bba52 
complementation.  
I therefore, decided to implement a new strategy to restore bba52 expression in 
the deletion mutant by the replacement of wild type copy of bba52 in the native locus.  
To accomplish this, I engineered a new construct using the bba52 mutagenesis plasmid 
pXLF10601-bba52.  A new primer set, P1 and P11, was designed to extend the P1P2 
flanking region incorporating the ORF of bba52.  Simultaneously, I amplifed by PCR the 
aadA cassette with the flgB promoter using a set of primers P12 and P13 and pKFSS1 as 
a template.  The P1P11 amplicon was ligated with the flgB-aadA cassette (P12P13 
amplicon) using the plasmid (pECFPC-1) having compatible multiple cloning sites 
(MCS3) in the sequence of SacI, EcoRI and BamHI.  The insert, P1P13 was digested out 
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from this plasmid (MCS3) and replaced with the old P1P2 flanking region of 
pXLF10601-bba52 constructed for mutagenesis. This new plasmid is referred as the 
bba52 complemented construct.  bba52 deletion mutant was transformed with 25 µg of 
bba52 complemented construct, as described before in section 3.3.2.  All other 
procedures for bba52 complementation were followed in the similar manner as described 
for deletion of bba52 gene.  The transformants were selected using kanamycin (350 
µg/ml) and streptomycin (100 µg/ml).  PCR analysis confirmed that one of the bba52-
complemented isolates retained all endogenous plasmids, except for the loss of the 
nonessential plasmid lp5.  
3.3.4 Confocal microscopy 
 Confocal immunofluorescence of tick salivary glands was performed using an LSM-510 
laser-scanning microscope (Zeiss), as detailed elsewhere (Pal et al., 2004a; Pal et al., 
2004b).  Samples for each time point of the analysis were dissected from a minimum of 5 
ticks, and whole organs were scanned at 0.6-mm intervals through the full tissue 
thickness.  Spirochetes were detected using fluorescein isothiocyanate– labeled anti–B. 
burgdorferi goat immunoglobulin (Ig) G (KPL), whereas tick salivary glands were 
labeled with Texas-Red phalloidin (Invitrogen). 
 
3.4 Results  
 
3.4.1 Gene expression of bba52 during representative experimental enzootic cycle of 
B. burgdorferi in ticks and mice 
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I assessed bba52 expression in detail during representative phases of the B. 
burgdorferi infection cycle.  Mice (10 animals/group) were infected with B. burgdorferi 
(10
5
 cells/mouse).  Total RNA was isolated from skin, joint, heart, and bladder samples at 
1, 2, and 3 weeks after infection and was pooled by tissue type.  Ticks were parasitized 
on parallel groups of mice that had been infected for 2 weeks (25 nymphs or 30 
larvae/mouse), and engorged ticks were isolated.  Fed intermolt nymphs were analyzed at 
25 days after feeding, whereas larvae were allowed to molt to nymphs.  Newly molted 
infected nymphs were allowed to feed on naive mice (10 ticks/mice) and were collected 
after 12–48 h of feeding.  Skin samples were also collected from mice after 5 days of tick 
engorgement.  Total RNA was prepared and subjected to qRT-PCR analysis to measure 
bba52 transcripts and was normalized against flaB.  The results showed that bba52 
transcripts were undetectable in mice during persistent infection or early tickborne 
infection, but they were obvious at all tested stages of B. burgdorferi infection in ticks, 
with the highest levels noted during tick feeding (FIGURE 2). 
 
3.4.2 B. burgdorferi mutant with deleted bba52    
I next generated bba52 deletion mutant as detailed in Materials and Methods. 
Transformation of wild type B. burgdorferi was performed using mutagenesis plasmid 
construct pXLF10601-bba52 to replace entire BBA52 ORF with kanamycin cassette 
driven by flaB promoter using allelic exchange.  I obtained about 5 transformant clones, 
in which bba52 gene was successfully deleted.  For confirmation of the desired 
integration of mutagenic construct, PCR was performed using a variety of primer 
combination.  Primers P5 and P6 were designed downstream of P1 and upstream of P4.  
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Primer P5 and kanamycin reverse primer P10 were used to amplify DNA template of 
mutant and wild type B. burgdorferi (FIGURE 3B).  Primer P5 was designed upstream of 
P1 primer sequence to differentiate the amplicons originated from mutagenic plasmid 
contamination or from the mutant genome.  In the similar manner, primer P6 and 
kanamycin forward P9 were used to amplify the wild type and mutant genome.  The ORF 
of kanamycin can be amplified only in the mutant and the ORF of BBA52 can only be 
PCR amplified from the wild type genomic DNA.  Next plasmid profile of one of the 
mutants, which was similar to wild type B. burgdorferi, was used for the rest of the study.  
To accomplish this, the 21 endogenous plasmids contained by the parental isolate were 
checked by PCR amplification using plasmid specific primers as described before (Zhang 
et al., 2009).  Mutants  maintaining all the plasmids except lp5, which is known to be not 
essential for infectivity of B. burgdorferi (Li et al., 2006) was selected for further study.  
RT-PCR was also performed with bba52 primer and its adjacent gene bba51 and bba53 
to verify for potential polar effects of gene manipulation (FIGURE 3D).  To compare the 
protein profile of bba52 mutant and wild type, lysates were resolved parallel to each 
other on a SDS-PAGE gel and then stained with coomassie brilliant blue.  After staining, 
the gel was destained for an hour using destaining solution. The protein profiles of the 
wild type and the mutant were similar (FIGURE 3D).  Immunoblot was next performed 
using the full length BBA52 antibody and FlaB as a positive control after resolving the 
wild type and mutant lysates on a SDS-PAGE followed by its transfer onto a 
nitrocellulose membrane.  A clear band at 33 kDa was visible in the wild type and absent 
in the mutant, whereas FlaB bands showed equal load of wild type and mutant B. 





Figure 2. bba52 expression is vector-specific. 
 bba52 expression was analyzed at various stages of murine and tick infectivity. RNA was isolated from 
mice (10 animals/group) at 1, 2 and 3 weeks after B. burgdorferi infection and pooled by tissue types 
(Skin, heart, joint and bladder). Naïve larvae and nymphs were allowed to feed on B. burgdorferi-
infected mice (25 ticks/mice) and collected at 96 h (fed larva and fed nymph) or 25 days following 
feeding (intermolt nymph). B. burgdorferi-infected nymphs (10 nymphs/mouse) were allowed to feed on 
naïve mice and collected at 12 h, 24 h, and 48 h of feeding.  Murine skin samples were collected 
following 5 days of tick engorgement. RNA samples from murine and tick samples were analyzed by 
qRT-PCR and presented as copies of bba52 transcript per copy of flaB transcript. Error bars represents 










Figure 2. bba52 expression is vector-specific. 
 bba52 expression was analyzed at various stages of murine and tick infectivity. RNA was isolated from 
mice (10 animals/group) at 1, 2 and 3 weeks after B. burgdorferi infection and pooled by tissue types 
(Skin, heart, joint and bladder). Naïve larvae and nymphs were allowed to feed on B. burgdorferi-
infected mice (25 ticks/mice) and collected at 96 h (fed larva and fed nymph) or 25 days following 
feeding (intermolt nymph). B. burgdorferi-infected nymphs (10 nymphs/mouse) were allowed to feed on 
naïve mice and collected at 12 h, 24 h, and 48 h of feeding.  Murine skin samples were collected 
following 5 days of tick engorgement. RNA samples from murine and tick samples were analyzed by 
qRT-PCR and presented as copies of bba52 transcript per copy of flaB transcript. Error bars represents 
the mean±SEM from four qRT-PCR analysis of two independent murine –tick infection experiments.  
 
 
Figure 3.  Construction and analysis of bba52 mutant B. burgdorferi.  
 (A). Schematic representation of wild type (WT) and bba52 mutant (bba52-) B. burgdorferi at the bba52 
locus.  Genes bba50-bba55 (white box arrows) and the kanamycin-resistance cassette driven by the B. 
burgdorferi flaB promoter (flaB-Kan, black box arrow) are indicated.  The regions up- and down-stream 
of the bba52 locus were amplified using primers P1-P4 (black arrow-heads) and ligated on either side of 
the flaB-Kan cassette to obtain the mutagenic construct, as detailed in the text.  (B) Integration of the 
mutagenic construct, flaB-Kan, in the intended genomic locus.  Primers 5-10 (gray arrowheads, positions 
indicated in figure 3A) were used for PCR analysis using isolated DNA from wild type (WT) or mutant B. 
burgdorferi (bba52-) and subjected to gel electrophoresis.  The combination of primers used for PCR is 
indicated at the top, and migration of the DNA ladder is shown on the left. (C) Reverse-transcription PCR 
assessment of bba52 transcripts and the polar effects of mutagenesis. (D)  Protein analysis of wild-type B. 
burgdorferi (WT) and bba52 mutant (bba52-).  Equal amounts of protein were separated on an SDS-
PAGE gel, and either stained with Coomassie blue (left panel) or transferred onto a nitrocellulose 
membrane and probed with BBA52 and FlaB antibodies (right panels).  Migration of protein standards is 




3.4.3 Growth of wild type and mutant in vitro 
I assessed for the deletion effect of bba52 by comparing the growth of mutant and 





 cells per ml.  Cells were counted by using Petroff-Hausser cell 
counting chamber under dark field microscopy in triplicates on every 24 h for 140 h 
(FIGURE 4). There was no significant difference in the growth of the mutant lacking 
bba52 gene compared to that of wild type B. burgdorferi. 
 
3.4.4 Assessment of bba52 deletion mutant for its stability to persit in an 
experimental enzootic life cycle of B. burgdorferi 
 
Figure 4. Comparative in vitro growth curves of WT and bba52 mutant. 
Spirochetes were diluted to a density of 10
5 
cells/mL and grown at 34°C in BSK-H medium. Triplicate 
samples were counted under a dark field microscope by use of a Petroff-Hausser cell counter.  








Figure 5. Full infectivity of bba52 mutant B. burgdorferi in mice.  
 
 The pathogen burdens in multiple tissues of infected mice are shown. Mice (15 
animals/group) were infected with wild-type (WT) or bba52 mutant (bba52-) isolates, 
and spirochete burdens were analyzed in skin (S), heart (H), joint (J), and bladder (B) 
samples, by measuring copies of B. burgdorferi flaB RNA at 2, 3, and 12 weeks of 
infection. Amounts of murine β-actin in each sample were determined and used to 
normalize the quantities of spirochete RNA. Bars denote the mean value ± standard error 
(SE) of quantitative reverse-transcription polymerase chain reaction analyses from 2 
independent infection experiments. The difference between WT and bba52 mutant levels 
was statistically insignificant at all time points and in all tissues (P> 1 .05). 
 
I first compared the ability of bba52 mutants to persist in mice.  Groups of mice 
(3mice/group) were injected with the bba52 mutant or wild type spirochetes (10
5
 
spirochetes/animal).  Animals were sacrificed after 1,2,3,4 and 12 week of 
infection. Tissues such as skin, heart, joint and bladder were collected and pooled 
together for extraction of RNA using Trizol as detailed in section 2.2.3.  B. 
burgdorferi burden in tissues were determined by qRT-PCR by using flaB primers 
and mouse β-actin primers for normalization of spirochete load (FIGURE 5).  The 
results expressed as copies of flaB per 10
6
 copy of the mouse β-actin.  I did not 
observe any significant difference in the B. burgdorferi load in any tissues 
compared to the wild type isolate.  I also assessed for the difference in the disease 
60 
 
pathogenesis, between mutants versus wild type infection.  To assess this, 
swelling in the ankle joints between weeks 0 - 4 of infection was measured using 
a digital caliper and isolated joints were analyzed for histopathological signs of 
Lyme arthritis using published procedures (Zhang et al., 2009).  There was no 
difference in the intensity of joint inflammation developed between wild type and 
mutant infection (FIGURE 6).  This data was in agreement with the 
histopathology of the mice ankle joint as well.  The outcome of the result showing 
a lack of phenotypic defects of bba52 mutation generally supports the bba52 
expression pattern, where I could not detect the bba52 transcripts in mice.  Instead 
this protein is exclusively expressed in the vector and thus likely required 
spirochete enzootic cycle where it is expressed, such as in the vector.  Thus, I was 
interested to assess the phenotype of the mutant in ticks during spirochete 
acquisition in ticks, their persistence throughout the intermolt stages and 









Figure 6. Assessment of joint swelling in B. burgdorferi– infected mice.  
Groups of mice (3 animals/group) were infected with WT or bba52- and were examined for joint swelling, 
by use of a digital caliper, at 0, 2, 3, and 4 weeks after spirochete challenge. Data denote the mean ± SE 
from 2 independent infection experiments. No difference in the ability of the WT and bba52- to induce 





3.4.5 Complementation of bba52 gene in mutant 
As complementation is necessary to follow molecular Koch‟s postulate showing 
any observed phenotypic defects of bba52 gene deletion is due to the loss of target gene, 
I intended to complement the gene.  My repeated attempt to transform the mutant to 
replace the bba52 gene back to the mutant was unsuccessful.  Therefore, I developed a 
novel strategy to replace, the bba52 gene at the original locus.  Our conventional 
approaches to construct mutagenic constructs to complement the B. burgdorferi as 
previously described (Promnares et al., 2009; Yang et al., 2009; Zhang et al., 2009) failed 
to recover any transformant.  Although, the complementation construct where bba52 
expression was driven by the flaB promoter was able to produce recombinant BBA52 in 
E.coli, but failed to isolate a BBA52-producing complemented clone in B. burgdorferi.  
The final approach to complement bba52 gene at the same locus was achieved using the 
same mutagenesis plasmid pXLF-10601, as described in detail in section 3.4.2 (FIGURE 
7).  The isolated complemented strains, which were able to grow in streptomycin and 
kanamycin retained all the parental plasmids and expressed bba52 mRNA and protein.  
RT-PCR analysis using the RNA isolated from wild type, mutant and complemented 
isolates confirms comparable transcripts synthesis (FIGURE 8B).  As expected, the 
genetic manipulation process did not introduce polar effects in complemented isolates, as 
assessed by the transcription of the surrounding genes bba51 and bba53 (FIGURE 8B).  
FIGURE 8C shows the comparative protein analysis of wild type, mutant and 
complemented isolates, as detected by staining with Coomassie brilliant blue.  
Immunoblot was also performed using anti-BBA52 antibody that indicated re-production 
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of BBA52 in the complemented isolate.  As a positive control, FlaB antibody was used to 










































Figure 8. Genetic complementation of bba52 mutant Borrelia burgdorferi.  
(A) Construction of the bba52-complemented construct for reinsertion of bba52 in cis, in the original gene locus of 
the lp54 plasmid. A new 5‟ arm was generated using primers P1–P11 and P12–P13, which were used to amplify 
and assemble 2 DNA inserts surrounding bba52 and aadA cassette with the flgB promoter, respectively. The insert 
representing P1–P13 amplicon (new 5‟ arm) was fused with the flaB-Kan cassette carrying the old 3‟ arm (as 
generated using P3–P4) (Figure 3A) to obtain bba52 complemented construct, and it was integrated in the B. 
burgdorferi lp54 locus via homologous recombination. (B) Reverse-transcription polymerase chain reaction (PCR) 
analysis of the bba52 complemented isolate. Total RNA was isolated from either the wild-type (WT), bba52 
mutant (bba52-) or bba52-complemented B. burgdorferi (bba52 Com); converted to complementary DNA; 
subjected to PCR analysis with flaB and bba52 primers; and analyzed on a 1.5% agarose gel (upper panel). bba52 
complemented isolates did not display polar effects on the transcription of genes surrounding bba52 locus (bba51 
and bba53) (lower panel). (C) Production of BBA52 protein in the complemented B. burgdorferi. Spirochete lysates 
were separated on a sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel, stained with 
Coomassie blue (left panel), or transferred to nitrocellulose membrane and probed with BBA52 and FlaB 





3.4.6 Phenotype of bba52 mutant B. burgdorferi in ticks during spirochete 
acquisition, persistence and transmission.  
Although both wild-type spirochetes and bba52 mutants persisted at similar levels 
in the murine dermis throughout the infection (FIGURE 5), the mutant was significantly 
impaired in its ability to transmit to naive ticks. To ensure the specificity of the result, I 
sought to complement the mutants with a wild-type copy of the bba52 gene in cis and use 
this isolate in mouse-tick transmission studies. I then assessed whether BBA52 is 
required for B. burgdorferi entry and persistence in and transmission through ticks.  To 
examine the effect of the bba52 deletion on spirochete acquisition by ticks, larval and 
naive nymphal ticks were allowed to parasitize mice that had been infected with wild-
type, bba52 mutant, or bba52-complemented isolates. The generation of larvae to 
Nymphs has been schematically represented in FIGURE 10.  Partially fed nymphs were 
forcibly removed at 24 and 48 h after the onset of feeding, and parallel groups of larvae 
or nymphs were collected as fully engorged ticks. The spirochete burden was assessed by 
qRT-PCR analysis of flaB normalized against tick β-actin levels.  Compared with wild-
type or bba52-complemented isolates, the levels of bba52 mutants were significantly 
lower in feeding ticks analyzed at 24 h (P < .002) and 48 h (P < .02) of host attachment 
(FIGURE 9A).  However, analysis of fully engorged larvae or nymphs at 7 and 25 days 
after feeding (FIGURE 9B) showed similar burdens of wild-type and mutant spirochetes, 
suggesting that bba52 deletion only transiently affected B. burgdorferi acquisition by 
ticks, without having significant influence on microbial persistence in the ticks.  I then 
compared the ability of the bba52 mutants to transmit back from infected ticks to naive 
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mice.  Separate groups of nymphs that were naturally infected with wild-type or mutant 
isolates were allowed to feed on naive C3H mice (9 animals/group) and were collected as 


















Spirochete burdens in ticks were assessed by qRT-PCR and confocal 
immunofluorescence analyses.  After 7 days of feeding, mouse infection was assessed by 
culture analysis of the heart and spleen samples and by qRT-PCR analysis of skin, heart, 
 
Figure 9. Impaired ability of bba52 mutant  B. burgdorferi to be transit between murine hosts and 
ticks.  
 (A) B. burgdorferi burdens in ticks during acquisition from infected mice. Mice were infected with 
B. burgdorferi (3 mice/group), and after 2 weeks of infection, naive Ixodes scapularis larvae or 
nymphs (25 ticks/mouse) were allowed to feed on mice.  B. burgdorferi burdens in ticks were 
analyzed by quantitative reverse transcription polymerase chain reaction (qRT-PCR) analyses at the 
indicated time intervals after feeding, by measuring the no. of copies of the B. burgdorferi flaB 
RNA and normalizing against tick β-actin RNA.  Bars denote the mean ± standard error (SE) of 2 
independent infection experiments. Differences in the spirochete burdens in ticks infected with 
bba52- and those with the bba52- complemented (bba52 com) isolates or wild-type (WT) 
spirochetes were significant both at 24 h (* P < .002) and 48 h (*P < .02). (B) B. burgdorferi 
burdens in postfed ticks.  Nymphs were allowed to engorge on infected mice, as shown in panel A, 
and B. burgdorferi burdens in postfed ticks were analyzed by qRT-PCR analyses at the indicated 
time intervals, by measuring the number of copies of B. burgdorferi flaB RNA and normalizing 
against tick β-actin RNA.  Bars denote the mean± SE of 2 independent infection experiments. 




and bladder tissues.  Results indicated that burdens of wild-type and bba52 mutants were 
similar in fed tick gut; however, the bba52 mutant was highly impaired in its ability to 
migrate to salivary glands (FIGURE 12) and transmit to mice (FIGURE 11).  Both wild-
type and bba52 complemented isolates were recovered by culture analysis of murine 
spleen and heart samples.  In contrast, the bba52 mutant remained undetectable in all of 
the 6 individual mouse spleens analyzed, but it was recovered from 4 of the 6 heart 
samples. This observation indicates that a minor proportion of bba52 mutants that 
remained untraceable in immunofluorescence and qRT-PCR analyses are still capable of 
transmission.  Collectively, these data establish that BBA52 function is nonessential for 
the persistence of B. burgdorferi in murine hosts or ticks but that it facilitates 














Figure 10.   A schematic diagram showing major steps in generation of infected nymph after feeding naïve 



























Figure 11. B.  burgdorferi transmission from infected ticks to mice.  
 
 B. burgdorferi–infected nymphs were generated by feeding larvae on mice infected with WT and 
genetically manipulated spirochetes, as described in the text. Newly molted B. burgdorferi–infected 
nymphs were allowed to feed on naive mice (1 tick/mouse and 3 animals/group).  B. burgdorferi burdens 
were assessed in the indicated murine tissues by qRT-PCR analyses performed after 1 week of tick feeding, 
by measuring the number of copies of B. burgdorferi flaB RNA, and they were normalized against mouse 




Figure 12.  B. burgdorferi localization in infected salivary glands during transmission.  
 A confocal orthogonal image display of infected salivary glands in the xz-axis and yz-axis revealing the 
distribution of spirochetes through the full thickness of the 60 h fed salivary glands is shown. The 
spirochetes (arrow) were labeled with fluorescein isothiocyanate–labeled goat anti–B. burgdorferi antibody 
(green), and gland morphologic findings were revealed by labeling of acinar actin filaments with Texas 
Red–phalloidin (red). Although WT and bba52 com were occasionally observed within the gland, bba52- 





3.4.7 Phenotype of bba52 mutant at late stage of mice infection when transmitted by 
ticks 
Since my previous transmission studies suggest that low levels of bba52 mutant 
were able to transmit and could be recovered by culture, I was interested in assessing 
bba52 persisitence for establishment of long-term infection such as 4 week after tick-
borne infection. To accomplish this, I microinjected the wild type, mutant and 
complemented B. burgdorferi isolates in naïve ticks.  After 5 days of microinjection, two 
ticks were fed on each mouse for assessment of B. burgdorferi transmission.  At 4 week 
of tick transmission, each group of mouse was sacrificed and specific tissues were pooled 
as described in section 2.2.3.  Spirochete burden was measured in the mouse as 
previously described.  FIGURE 13 shows that the mutant B. burgdorferi can be detected 
in late stage of infection by qRT-PCR although there is significant difference in bacterial 












Figure 13. Spirochete load in mice at 4 week of tick transmission.  
Ticks were microinjected with WT, mutant and complemented B. burgdorferi. After 5 days of 
microinjection, two ticks were fed on each mouse for assessment of B. burgdorferi transmission.  At 4 
week of tick transmission, each group of mouse was sacrificed and specific tissues were pooled for RNA 
extraction.  Spirochete burden was measured in the mouse by qRT-PCR as copies of flaB/ mouse β actin. 






     B. burgdorferi has developed remarkable abilities to persist in a complex enzootic cycle 
involving wild rodents and arthropods (Lane et al., 1991).  While a tick engorges on the 
host blood meal, the pathogen transits between the radically different tissue environments 
of mammals and arthropods.  As membrane proteins, including microbial adhesins 
(Coburn et al., 2005), may greatly contribute to pathogen interaction with new 
environments, I assessed the expression of selected spirochete gene products with 
putative membrane-localization signals (Yang et al., 2009).  I identified bba52 as one of 
the genes that is selectively expressed in ticks and show that BBA52 facilitates microbial 
transitions between the vector and the host (Kumar et al., 2010).  bba52 gene deletion 
studies shows that there is no difference in  growth  and pathogenesis using mouse as a 
animal model whereas phenotype was obvious  during the tick phase of B. burgdorferi 
enzootic cycle. 
   B. burgdorferi undergoes notable changes in antigenic composition as it invades 
and colonizes diverse tissues in arthropods or mammals (Fingerle et al., 2002; Liang et 
al., 2002c; Narasimhan et al., 2003; Narasimhan et al., 2002a; Schwan et al., 1995; Tilly 
et al., 2008; Yang et al., 2009).  These changes are partly mediated by known regulatory 
network, involving Rrp2-RpoN/RpoS or Rrp1–Hpk1 TCS and c-di-GMP (Boardman et 
al., 2008; Caimano et al., 2007; Hubner et al., 2001; Rogers et al., 2009b; Xu et al., 
2010; Yang et al., 2003).  However, recently it has been proposed that activation of the 
Rrp2-RpoN-RpoS pathway occurs via the small, high-energy, phosphoryl-donor acetyl 
phosphate (acetyl~P), the intermediate of the Ack-Pta (acetate kinase-phosphate 
acetyltransferase) pathway that converts acetate to acetyl-CoA rather than by histidine 
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kinases (Xu et al., 2010).  Microarray analyses of transcriptional alterations in cultured 
spirochetes identified a large number of genes that are differentially expressed, including 
bba52, which responded to physiochemical alterations including variations in 
temperature, the addition of blood, or growth in a dialysis membrane chamber (DMC) 
implanted within the murine host (Brooks et al., 2003; Caimano et al., 2007; Ojaimi et 
al., 2002; Tokarz et al., 2004).   
  BBA52 is encoded by the linear plasmid (lp) lp54, which, unlike many other B. 
burgdorferi linear or circular plasmid (cp)s, is a stable extra-chromosomal element and 
considered as an integral part of core spirochete genome (Terekhova et al., 2006).  lp54 
retains a large number of paralogous genes and shares multiple blocks of sequence 
homologies with cp32-based plasmids (Casjens et al., 2000b).  For example, the DNA 
block harboring genes bba38-bba55 in lp54 is significantly homologous to cp32-1 DNA 
housing bbp1-bbp18 with unidirectional ORFs (Casjens et al., 2000b; Fraser et al., 
1997a).  However, lp54 contains a few unique intervening insertions, including the bba52 
locus, within these homologous (cp32-like) DNA blocks.  Incidentally, other unique loci 
in lp54 encode for OspA/B and DbpA/B, which are differentially expressed in vivo and 
contribute to microbial persistence in arthropods (Yang et al., 2004) and mammalian 
hosts (Blevins et al., 2008; Shi et al., 2008), respectively.  Therefore, I speculate that the 
occurrence of bba52 as a unique locus in one of the few stable plasmids of B. burgdorferi 
(Stewart et al., 2005), possibly signify an important role for BBA52 in maintaining the 
microbial life cycle.  This is supported by my findings that bba52 is expressed in vivo, 
confined to the vector-specific microbial life cycle with highest levels of expression 
during tick feeding.  Consistent with undetectable bba52 expression in murine hosts, 
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BBA52-deficient spirochetes lack an obvious phenotypic defect in mice.  In contrast, 
bba52 ablation affected B. burgdorferi persistence in feeding ticks during microbial 
entry, and to greater extents, severely impeded pathogen migration to tick salivary glands 
and transmission to mice.  Therefore, BBA52 function is highly relevant during microbial 
transitions between the vector and hosts, which is essential for successful maintenance of 
the pathogen through the complex enzootic cycle.  
  Identification of B. burgdorferi gene products important for infectivity is made largely 
possible by seminal discovery of borrelial genetic transformation process (Samuels, 
1995) and further progress in borrelial mutagenesis (Rosa et al., 2005).  However, the 
unusual organization of spirochete genome and lack of promoter information poses 
serious challenges to the genetic complementation efforts, as I encountered for bba52.  
The ORF of 14 consecutive genes upstream of bba52 are unidirectional, encode mostly 
hypothetical proteins, lack a discernible promoter and possess overlapping or short 
intergenic regions.  A majority of them display similar environmental regulatory 
responses, such as enhanced transcript levels in spirochetes grown at 23ºC relative to 
37ºC (Ojaimi et al., 2002), thus indicating a potentially linked expression profile.  bba52 
shares a short (40 base pairs) intergenic region with bba51; however, use of this 
intergenic sequence as a native promoter to drive bba52 expression in B. burgdorferi was 
unsuccessful.  E. coli was able to produce BBA52 when transformed with bba52 ORF 
driven under heterologous and constitutively-active borrelial promoter, flaB.  Noticeably, 
the flaB promoter failed to restore bba52 expression in B. burgdorferi, possibly indicating 
that constitutive expression of bba52 is detrimental to spirochetes.  This problem is not 
limited to genetic manipulation of bba52.  Use of constitutively-active heterologous 
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promoters or native promoters when placed in non-native cis locations or in shuttle 
vectors could potentially result in aberrant gene expression that can complicate 
phenotypic analysis.  Thus, genetic complementation of differentially regulated borrelial 
genes remains technically challenging, however, in the current case; I was able to 
complement bba52 by replacing the gene in its native cis location without apparent polar 
effects and fully restored wild type phenotypes.  This strategy could be helpful for 
complementation efforts of other regulated borrelial genes, particularly those lacking 
discernible promoters yet are retained in an optimal borrelial locus amenable for genetic 
manipulation.  
  Although I have determined that BBA52 participates in pathogen transitions 
between the host and the vector, with the most prominent role during pathogen exit from 
ticks to mice, the function of this gene product in spirochete biology remains unknown.  
However, correlated with tick-specific expression of bba52 and significant extracellular 
exposure of the antigen, BBA52 might be involved in pathogen interaction with vector 
environments.  Based on the temporal upregulation of the bba52 in feeding ticks and 
phenotypic analysis of bba52 mutants in vivo, I propose that BBA52 facilitates spirochete 
transitions between murine hosts and ticks by assisting pathogen persistence in rapidly 
changing environments of the feeding tick gut (Sonenshine, 1993) or its migration 
between the host dermis and vector gut.  BBA52 is likely conserved in major B. 
burgdorferi isolates as generated BBA52 antisera readily recognized the native protein in 
N40 and 297 isolates, and retained 65-68% amino acid identity across orthologs in B. 
afzelii and B. garinii.   Characterization of surface-exposed microbial antigens expressed 
in feeding arthropods provides an opportunity to understand the pathogen interactions 
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with environments likely required for microbial transition between hosts and vectors, and 





















Chapter 4: Characterization of BBA52 - localization, function 
and its potential as a transmission blocking vaccine 
 
 Abstract  
BBA52,  annotated as a conserved hypothetical protein of B. burgdorferi, is an 
outer membrane protein expressed exclusively in tick phase of Lyme disease enzootic 
cycle.  My proteinase K and immunfluorescence assay (IFA) shows BBA52 as a surface-
exposed protein.  Phase separation of B. burgdorferi proteins using Triton X-114 suggests 
that BBA52 is amphiphilic in nature as it could be detected in both aqueous and detergent 
phases.  Presence of BBA52 protein in detergent phase is consistent with IFA result 
showing BBA52 integration in the outer membrane (OM) of B. burgdorferi.  Far western 
analysis using recombinant BBA52 and B. burgdorferi proteome, showed the existence 
of two BBA52 interacting partners; one is located in outer membrane and the other in 
protoplasmic cylinder fraction of B. burgdorferi.  My data suggested BBA52 also 
interacts with a tick gut protein at ~ 35 kDa.  BBA52 was assessed as a potential 
candidate for transmission-blocking Lyme disease vaccine.  Immunization of mice with 
recombinant BBA52 protein conferred partial protection from Lyme disease during tick 
transmission indicating that BBA52 can be potentially used as a tick transmission- 
blocking vaccine.  Characterization of surface-exposed microbial antigens expressed in 
feeding arthropods provides an opportunity to understand the pathogen interactions with 
environmental factors that are likely required for successful microbial transition and 





Lyme borreliosis, caused by B. burgdorferi, is a vector-borne zoonosis prevalent 
in many parts of the globe (Piesman and Eisen, 2008a, b).  While feeding on an infected 
reservoir host, usually wild rodents, immature Ixodes ticks acquire the pathogen, 
transstadially maintain the infection and, during a subsequent blood meal, transmit the 
pathogen to mammals.  Selected mammalian hosts including humans manifest a wide 
array of clinical symptoms of Lyme borreliosis, frequently including the characteristic 
skin rash erythema migrans, arthritis, carditis and neurological symptoms (Steere et al., 
2004).  Inbred rodent hosts such as C3H mice, once infected with B. burgdorferi, develop 
some of the complications of Lyme borreliosis encountered by humans and are 
considered excellent animal models of Lyme borreliosis (Barthold, 1992).  Since rodents 
constitute the natural reservoir hosts of B. burgdorferi, murine models are also used to 
unravel the molecular details of spirochete infection and tick transmission cycle.    
B. burgdorferi houses an unique genome (Casjens et al., 2000b; Fraser et al., 
1997a) that enables the microbe to persist and cycle between dramatically different hosts.  
Identifying spirochete antigens expressed in vivo and understanding their functions in 
pathogen biology and infectivity are necessary to develop preventive measures against 
Lyme borreliosis.  However, such efforts face serious challenges due to the evolutionary 
distinctness of spirochetes from other bacterial species.  Although B. burgdorferi encode 
many gene products that have significant homology to other bacterial proteins, the major 
fraction of the spirochete genome, including 90% of the plasmid-borne genes, encodes 
for proteins with little resemblance to known virulence factors or proteins.  Thus, 
mechanisms of pathogen persistence and host interaction are likely different from more 
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well-studied bacterial pathogens (Casjens et al., 2000b).  The majority of spirochetal 
proteins are annotated as „hypothetical proteins‟; however, as many of them are indeed 
transcribed, at least in vitro (Brooks et al., 2003; Ojaimi et al., 2002; Revel et al., 2002b), 
they likely represent proteins with unidentified functions related to microbial persistence 
in a complex enzootic cycle.  Microarray and RT-PCR studies have revealed differential 
expression of a large number of borrelial genes with unique genetic regulatory networks, 
possibly relevant to microbial survival in a wide variety of tissue environments that 
spirochetes encounter in vivo (Brooks et al., 2003; Caimano et al., 2007; Fisher et al., 
2005; Liang et al., 2002a; Narasimhan et al., 2003; Ojaimi et al., 2002; Revel et al., 
2002b; Rogers et al., 2009b; Tokarz et al., 2004).  Despite identification of a handful of 
antigens critical for maintenance of a spirochete infectious cycle (Rosa et al., 2005), the 
function of most borrelial antigens remains elusive.   
B. burgdorferi persists in vivo for months to years, yet efficiently transits between 
new hosts or vectors during relatively short episodes of tick feeding (de Silva et al., 
2009).  As ticks attach to the host and take a blood meal, B. burgdorferi migrate between 
evolutionarily distant species.  Notably, only a small fraction of pathogens from an 
infected host or vector actually transmit, possibly ones that are accessible to the host-
vector interface.  For example, B. burgdorferi colonizes multiple internal organs in a 
host, however, during acquisition by ticks, spirochetes proximal to the dermal feeding 
lesion are the most likely to migrate to the vector.  Similarly, when infected ticks engorge 
on a mammal, spirochetes multiply exponentially in the gut (de Silva and Fikrig, 1995); 
however, only a minor fraction of B. burgdorferi migrate to the host dermis, possibly 
only those with the ability to exit the feeding gut and invade the salivary glands (Piesman 
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et al., 2001).  As antigenically and genetically-diverse populations of B. burgdorferi exist 
in vivo (Ohnishi et al., 2001), spirochetes that are maintained in an enzootic infection 
cycle might display favorable genetic regulation, for example ones regulated by sigma 54 
(Fisher et al., 2005), that facilitate vector-host transmission.  The mechanisms of 
spirochete transfer between host and vector, by active locomotion (chemotaxis) or by 
passive transfer (diffusion) through host body fluids or tick saliva, are unknown.  
Although the B. burgdorferi genome (Casjens et al., 2000b; Fraser et al., 1997a) harbor 
bacterial orthologs associated with spirochete locomotion (Li et al., 2000) and 
chemotaxis (Motaleb et al., 2007; Motaleb et al., 2005), and certain organs, such as tick 
salivary gland lysates contains chemoattractant for spirochete migration (Shih et al., 
2002), antigenic determinants and detailed mechanisms associated with the complex 
transmission process of spirochetes remains a subject of further investigation.  Previous 
genetic study against novel protein BBA52, which is exclusively expressed by B. 
burgdorferi in vector, showed that bba52 facilitates transmission of B. burgdorferi from 
ticks and mammals.  The identification of spirochete antigen that assist pathogen 
transmission between ticks and mammals, and understanding their biological function are 
important for the development of novel transmission-blocking approaches to intervene in 
Lyme borreliosis.  
 
4.2 Materials and Methods 
 




BBA52 antibodies bind to the surface of intact unfixed B. burgdorferi.  
Spirochetes were immobilized on glass slides and probed with BBA52 or control (GST) 
antibodies.  Antibody against known surface outer surface protein A (OspA) and 
subsurface lp6.6 (BBA62) spirochete proteins were used as controls.  Spirochete loading 
and antibody labeling was assessed using propidium iodide (PI) and Alexa-488 tagged 
secondary antibodies, respectively.  Images were acquired using a 40×objective lens of a 
Zeiss confocal microscope.  A borreliacidal activity of BBA52 antibodies in vitro was 
analyzed.  Spirochetes were incubated with either normal rabbit sera (NRS), rabbit OspA 
antibodies (OspA), serum collected from 15-day infected mice or BBA52 antibodies.  
The sensitivity of spirochetes to the bactericidal effect of the antibodies was assessed by a 
re-growth assay after 48 h of antibody incubation and presented as mean ± SEM of viable 
spirochete number (cells/ml).  The numbers of viable spirochetes were significantly 
reduced in the samples exposed to the OspA or B. burgdorferi antibodies, compared to 
spirochetes that received no treatment or were incubated with BBA52 or normal serum (P 
< 0.002).  
4.2.2 Proteinase K accessibility assay 
Proteinase K accessibility assays was performed as described before (Coleman et 
al., 2008).  Briefly, B. burgdorferi (2×10
8
) were gently washed three times in 1 ml of 
PBS (pH 7.4) and collected by centrifugation at 4,000×g for 4 min.  Washed spirochetes 
were then gently resuspended in 1 ml of PBS and split into two equal 500 µl volumes.  
One aliquot received 200 mg of Proteinase K (PK) (Sigma), while the other aliquot 
received an equal volume of PBS without PK.  Both aliquots were incubated for 1 h at 
room temperature before the addition of 10 µl of phenylmethylsulfonylfluoride (PMSF) 
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(Sigma) to stop PK activity.  Spirochete suspensions were subsequently pelleted by 
centrifugation at 10,000×g for 10 min and resuspended in PBS for immunoblot analysis  
using antibodies against FlaB (1:200), OspA (1:200) and BBA52 (1:15000). 
 
4.2.3 Purification of outer membrane vesicles and immunoblotting 
 Isolation of outer membrane vesicles (OMV) of B. burgdorferi was performed as 
described (Skare et al., 1995).  Briefly, 1×10
11
 B. burgdorferi cells were washed in 
phosphate-buffered saline pH 7.4 (PBS) supplemented with 0.1% BSA.  The cells were 
resuspended in ice-cold 25 mM citrate buffer pH 3.2 containing 0.1% BSA and incubated 
on a rocker at room temperature for 2 h.  OMV were released from whole cells and were 
isolated from protoplasmic cylinder (PC) using sucrose density gradient centrifugation.  
For localization of BBA52, immunoblotting was performed using equal amounts 
(0.3µg/lane) of OMV and PC, and probed with either BBA52 (1:5000), FlaB (1:200), or 
OspA (1:200) antibodies. 
4.2.4 Phase separation of integral membrane proteins in Triton X-114 solution 
  The protein samples were prepared as described before (Bordier, 1981).   Briefly, 
1×10
9
 spirochetes grown in BSK medium were spun and washed 3 times with PBS.  The 
pellet obtained was resuspended in 800 µl of PBS and sonicated four times with 20 sec 
burst each.  Thereafter, 200 µl of 10% Triton X-114 was added to it and was rocked 
overnight at 4°C.  The insoluble debris was removed by centrifugation at 13000×g for 15 
min at 4°C and placed at 37°C water bath for 10 min.  The suspension was centrifuged 
for 10 min at 13000× g at room temperature to separate detergent and aqueous phase.  
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The detergent phase and aqueous phase was washed as follows.  The detergent phase 
(50µl) was mixed to 1 ml of original buffer at 0°C, rewarmed at 37°C and spun in a 
microcentrifuge as before.  Later, the final aqueous phase and detergent phase obtained 
after four rounds of wash was precipitated with 10 volumes of chilled acetone.  The 
aqueous and detergent phase was mixed with equal volume 2×Laemmli buffer (BioRad) 
and heat denatured at 95°C for 10 min.  Immunoblot was performed with aqueous and 
detergent phase proteins using BBA52 and BBA74 antibodies.  BBA74 antibodies were 
used as a control which is known to be present in aqueous phase (Mulay et al., 2007). 
4.2.5 Osmotic shock assay   
 Osmotic shock assay was performed as detailed (Elias et al., 2000) with minor 
modifications.  Briefly, stationary-phase B. burgdorferi cultures were incubated for 40 
min at 34°C in the presence or absence of 1 M NaCl in BSK medium.  Thereafter, 
aliquots were inoculated in fresh BSK medium and were allowed to re-grow for 48 h at 
34°C.  The number of viable spirochetes was counted using Petroff-Hausser cell counter 
under dark field microscopy.  
4.2.6 Oxidative stress assay  
 For determination of spirochete susceptibility to oxidative stress (Boylan et al., 
2008), B. burgdorferi (10
7
cells/ml) grown in BSK  medium was treated with hydrogen 
peroxide at concentrations of 1-10 mM.  In a parallel control, the hydrogen peroxide was 
replaced with equal volumes of nuclease-free water.  After incubation for 24 h at 34°C, 




4.2.7 Detergent treatment assay 
 The outer membrane integrity of the spirochetes was assessed using a detergent 
treatment assay as described before (Slavik, 1982), with the following modifications.  
Spirochetes in BSK medium (10
7
 cells/ml) were incubated in the absence or presence of 
SDS (2 mg/ml).  Following 4 h incubation at 34°C, cells were pelleted by centrifugation 
at 12000 rpm for 10 min.  Five µl of the supernatant was diluted in 100 µl of PBS.  DNA 
was extracted from this mixture using phenol:chloroform extraction and analyzed by 
quantitative PCR (Coleman et al., 2008) to measure the amount of cellular DNA released 
in the supernatant. 
4.2.8 Confocal immunofluorescence microscopy 
 Confocal immunofluorescence of tick gut and salivary glands were performed 
using LSM-510 laser scanning microscope (Zeiss) as detailed earlier (Pal et al., 2004a; 
Pal et al., 2004b).  Samples for each time point of analysis were dissected from a 
minimum of 5 ticks and whole organs were scanned at 1 µm (gut) and 0.6 µm (salivary 
gland) intervals through the full tissue thickness.  Spirochetes were detected using FITC-
labeled anti-B. burgdorferi goat IgG (KPL), whereas tick gut and salivary glands were 
labeled with propidium iodide (Sigma) and Texas Red-phalloidin (Invitrogen), 
respectively.   
4.2.9 Immunization of mouse with recombinant BBA52 and tick transmission  
Recombinant BBA52 was produced in baculovirus expression system as 
described before in section 3.2.2.4.  A group of 5 mice were immunized with rBBA52 or 
PBS in Freunds complete adjuvant (FCA).  Antigen was prepared by syringe 
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emulsification of the adjuvant and the recombinant protein.  Each mouse was injected 
intradermally with 10 µg of recombinant BBA52 purified protein.  After 10 days of 
primary immunization, mice were given first booster doze of 10 µg of protein per mice in 
incomplete Freunds adjuvant (IFA).  After about 7 days, serum was collected from the 
mice to check the antibody development by performing immunoblot against B. 
burgdorferi lysate.  Mice were given the second booster after day 10 of the first booster. 
Later, after 5 days of second booster, wild type B. burgdorferi infected ticks (2 
ticks/mouse) were infested on mice immunized with PBS and rBBA52 antigen.  Repleted 
ticks fallen after complete feeding was collected to check by qRT-PCR, the infectivity of 
ticks with the spirochete.  After 10 days of tick feeding, mice were sacrificed and specific 
tissues were pooled together on group basis to extract RNA as described in section 3.2.1.  
Bacterial load was assessed in each tissue by qRT-PCR. Three independent experiments 
were done and the average values of three qRT-PCR results were statistically analyzed. 
4.2.10 Passive transfer of BBA52 antibodies and in vivo transmission-blocking 
  A microinjection procedure was used for the passive transfer of antibodies into 
the infected tick gut as previously described (Pal et al., 2004b).  Naturally-infected 
nymphs were generated by allowing larvae to engorge on B. burgdorferi-infected mice 
and molt to nymphs.  Two groups of nymphs (10 ticks/group) were injected with equal 
amounts of rabbit BBA52 antibody or normal rabbit antibody.  To assess effects of 
antibody-treatment on spirochete persistence in unfed ticks, one group of injected 
nymphs (5 ticks/group) kept in the unfed condition for 5 days and spirochete burden were 
determined by qRT-PCR and confocal immunofluorescence.  To assess the effects of 
BBA52 antibodies on spirochete transmission from ticks to mice, single antibody-
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injected ticks were fed on groups of two naïve mice and B. burgdorferi burden in the 
repleted ticks were determined by qRT-PCR analysis.  At day 7 following tick feeding, 
all the mice were sacrificed, and the tissues were isolated for the assessment of  
spirochete burden by qRT-PCR and culture analysis (Yang et al., 2009).  Two 
independent experiments were performed and the average of the results obtained was 
statistically analyzed. 
4.2.11 Infection of mice during active or passive immunization 
Groups of immunized mice after 5 days of second booster were anaesthetized by 
intraperitoneal injection of ketamine and xylazine.  While mice remained unconscious, 
two infected ticks per mouse were allowed to feed on each mouse, which were removed 
as repleted ticks.  For the passive immunization studies, I injected peptide antibodies into 
infected ticks via microinjection procedure (Pal et al., 2004b).  After 5 h of 
microinjection of BBA52 antibody in ticks, they were allowed to feed on naïve mouse 
until repleted ticks were recovered from each mouse.  At day 10 of tick feeding, mice 
were sacrificed to collect tissues for quantifying spirochete load in heart, joint and 
bladder as described in section 3.2.1.  Spirochete load was determined by quantifying 
copies of flaB per mouse β-actin. 
4.2.12 Far-western assay 
 Far-western, also known as gel-overlay assay was performed to identify possible 
interacting partner of BBA52 in the B. burgdorferi or the tick gut.  B. burgdorferi or 48 h 
fed tick gut was resolved in a SDS-PAGE gel and transferred to a nitrocellulose 
membrane.  The membrane was blocked with 5% of skimmed milk in TBS-T (0.05%) for 
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1 h and then 5-10 µg of rBBA52 which has a 6×His tag at N-terminus was overlayed on 
the nitrocellulose membrane in 5% skimmed milk, overnight at 4°C.  Separate controls 
were also processed in the absence of BBA52 protein.  Nitrocellulose membrane was 
washed 3 times with PBS-T (0.05%) and then was probed with anti-BBA52 antibody, 
followed by HRPO conjugated secondary antibody or directly anti His-HRPO conjugate. 
4.2.13 Enzyme-linked immunosorbent assay and confocal microscopy to assess 
protein binding in tick gut extract  
  Recombinant  BBA52 was expressed as a fusion protein with GST, as previously 
described (Zhang et al., 2009).  Guts from flat Nymphal ticks were microdissected in 
PBS and homogenized on ice with Kontes micro homogenizer.  About ten tick gut were 
dissected and homogenized in 1 ml of PBS.   Each well was coated with 100 µl of tick 
gut extract (TGE) and incubated overnight at 4°C.  On an average, 100 µl of TGE 
contains 0.5 µg of ticks gut protein determined by Bradford assay.  For control, 100 µl 
per well of PBS was added.  The plates were tightly covered with cellophane to avoid 
evaporation.  Plates were then washed three times with PBS-T (0.05%).  The TGE coated 
and control wells were blocked with 200 µl of 5% BSA for 2 h at 37°C.  Plates were then 
incubated with 100 µl of rBBA52 protein at a concentration of 1ng/µl at 37°C for 1 h.  As 
a control, plates were also incubated with equal quantity of GST protein.  Plates were 
then washed three times with PBS-T to remove non specific binding of BBA52 protein.  
Wells were then probed with 1:1000 dilution of anti-BBA52 in 100 µl solution per well 
for 1 h at 37°C.  After washing three times with PBS-T, plates were probed with anti-
mouse IgG conjugated with HRPO for 1 h at 37°C.  All wells were washed three times 
with PBS-T and then binding was detected with TMB microwell peroxidase substrate 
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(KPL Gaithersburg, MD) for color development.  The OD was measured at 450 nm 
wavelength, after 15 min of color development and adding of stop solution.  The 
assessment of protein binding by confocal microscopy was performed as previously 
described (Pal et al., 2004b).  About 10 tick guts were dissected from unfed nympal ticks 
in 100 µl of PBS.  The tissue was cut into pieces and placed on sialylated glass slides 
(PGC Scientific, Gaithersburg, MD) to increase adhesion efficiency.  Samples were 
incubated with PBS-T with 5% goat serum for 30 min at room temperature after washing 
three times with PBS.  Recombinant BBA52 protein was overlayed at a concentration of 
50 µg per ml for 1 h at room temperature.  As a control, recombinant BBA62 was 
overlayed on it, at similar concentration.  After three times wash, tissues were probed 
with anti-BBA52 serum at 1:1000 dilutions.  Secondary antibody against mice IgG 
conjugated with Alexa 488 was used to observe binding of BBA52 protein with tick gut.  
Samples were subsequently stained with propidium iodide (50 µl of a 10 µg per ml 
solution) for 5 min at room temperature and then washed three times with PBS-T, and 
mounted in glycerol for examination.  The tissues were viewed under Zeiss LSM 510 
scanning laser confocal microscope. 
 
4.2.14 Treatment of tick gut with trypsin 
TGE was prepared as described above followed by trypsinization of the tick gut to 
partially understand the biochemical character of BBA52 receptor as described before 
(Pal et al., 2000).  Equal aliquots of tick gut extract suspended in PBS were incubated 
with trypsin (Sigma) for 1 h at 37°C at 10 µg /ml concentration in the presence or 
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absence of 20 µg/ml of soyabean trypsin inhibitor (sigma).  After 1 h of enzymatic 
digestion of tick gut protein, the TGE and the enzyme treated samples were coated on 
microtiter plates and incubated with rBBA52 as described above in ELISA to find the 
BBA52 interaction. 
4.2.15 Two dimentional (2D) gel electrophoresis 
B. burgdorferi or tick gut protein was prepared in sample buffer as recommended 
by the manufacturing company (GE healthcare).  The IPG strip (GE healthcare) of pH 3-
10 was rehydrated overnight in in 125 µl volume of rehydration buffer.  Protein loading 
was performed on the IPG strips as per the instructions provided by the manufacturer 
(Ettan IPGphor cup loading manifold manual, GE healthcare) and was run on Ettan IPG 
phor II electrophoresis equipment  under following condition. 
S1     Stp       300V       0:30h 
S2     Grd      1000V     0:30h 
S3     Grd      5000V     1:20h 
S4     Stp       5000V     0:20h 
Where „S‟ stand for step; „Stp‟ for step “N” hold; „Grd‟ for gradient. 
 The IPG strip was run for total 2 h and 40 min under fixed and gradient voltage to 
increase the band sharpness.  After completion of electrophoresis, the IPG strip was 
equilibrated in SDS equilibration buffer for 15 min.  Thereafter, protein was further 
separated on the second dimensional SDS-PAGE. 
4.3 Results 
 




To obtain further information on potential function of BBA52 in spirochete 
biology, I assessed whether the antigen is present on the microbial OM and exposed to 
the extracellular surface.  To accomplish this, OM vesicle and protoplasmic cylinder (PC) 
fractions were separated from cultured spirochetes and subjected to immunoblot analyses 
using antibodies against BBA52, OspA and FlaB.  While FlaB was mostly undetectable 
in the OM, both BBA52 and OspA were readily detected in the OM (FIGURE 14A).  
Both immunofluorescence labeling of unfixed spirochetes (FIGURE 16A), and 
Proteinase K digestion of B. burgdorferi surface proteins (FIGURE 14B), suggested that 
BBA52 is exposed on the extracellular surface of the spirochetes.  Although bba52 
expression is responsive to environmental changes in vitro (Brooks et al., 2003; Ojaimi et 
al., 2002; Tokarz et al., 2004) and is differentially expressed in ticks, the in vitro growth 
kinetics of wild type and bba52 mutants did not differ.  When spirochetes are exposed to 
varied temperatures (23°C, 34°C and 37°C) (FIGURE 17), high salt concentration 
(FIGURE 18) and hydrogen peroxide (FIGURE 19), bba52 deletion did not interfere with 
B. burgdorferi survival, suggesting that BBA52 function may not be associated with 
spirochete adaptation to temperature and oxidative or osmotic stress in vitro.   Although 
BBA52 is localized on the OM, its deletion did not affect membrane integrity against 
detergent-mediated cell lysis (FIGURE 20).  My  phase separation experiment using 
Triton X-114  show that BBA52 can be detected in both aqueous phase (A) and detergent 
phase (D), providing evidence of being amphiphilic in nature and portion of being 
integrated in the B. burgdorferi membrane (FIGURE 14C).  Another property of BBA52 
is that the complete ORF contains 2 cysteine residues that have the tendency of forming 
intermolecular disulfide bond formation.  This is evident when the B. burgdorferi lysate 
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is resolved in SDS-PAGE without adding β-mercaptoethanol and then processed for 
immunoblot analysis using BBA52 antibody.  Results revealed, multiple bands at gel 
positions that correspond to approximate molecular weight of  monomeric, dimeric, 
trimeric and hexameric forms of BBA52 (FIGURE 15A).  The same feature of BBA52 
homo-oligomerization is also reflected by the baculovirally-produced recombinant 
BBA52 and other strains of B. burgdorferi (FIGURE 15C).  In the absence of β-
mercaptoethanol, each band corresponds to BBA52 monomer, dimer, Trimer, hexamer; 
appears as doublet (FIGURE 15A and C).  To prove BBA52 undergoes post translational 
modification, B. burgdorferi or the protoplasmic cylinder fractions were treated with N-
Ethylmaleimide (NEM) to prevent any disulfide bonding during protein preparation. 
There was no effect in migration of BBA52 protein as detected by immunoblot on NEM 
treated B. burgdorferi lysate (FIGURE 15B and D). The ability to form strong disulfide 
bond in BBA52 was compared with known OspC protein (FIGURE 15E), which conveys 









Figure 14. BBA52 is localized in the outer membrane and exposed to the microbial surface.  
(A) BBA52 is distributed in the outer membrane of cultured spirochetes. B. burgdorferi protoplasmic cylinders 
(PC) and outer membranes (OM) were separated by sucrose density gradient centrifugation and equal amounts of 
protein from two sub-cellular fractions were separated by SDS-PAGE, and immunoblotted with BBA52, OspA 
and FlaB antiserum. (B)  BBA52 is highly sensitive to proteinase K-mediated degradation of B. burgdorferi 
surface proteins. Viable spirochetes were incubated with (+) or without (–) proteinase K for the removal of 
protease-sensitive surface proteins and processed for immunoblot analysis using BBA52 antibodies.  B. 
burgdorferi OspA and FlaB antibodies were utilized as controls for surface exposed and sub-surface proteins, 
respectively.  (C) Phase partitioning assay using Triton X-114. Phase separation using Triton X-114 shows that 
BBA52 is located in both detergent phase (D) and aqueous phase (A) by immunoblot.  A known aqueous phase 























Figure 15.  BBA52 exists as oligomeric protein. 
 (A) Immunoblot showing oligomerization of native and recombinant BBA52 protein.  Lane 1 and 2 shows 
resolution of spirochetes in the presence or absence of β-mercaptoethanol.  Under nondenatured condition, BBA52 
forms dimer, trimer and hexamer whereas in denatured condition it exists as a monomeric protein of 33 kDa. 
Similar pattern is observed after resolving recombinant protein without (lane 3) and with β-mercaptoethnol (lane 
4). Lane 5 is BBA52 mutant lysate to show the specificity of immunoblot. (B) Immunoblot of N-Ethylmaleimide 
(NEM) and β-mercaptoethanol (β-ME) treated B. burgdorferi lysate.  Log phase grown B. burgdorferi were lysed 
in the presence or absence of 0.2 mg of NEM per 75 µg of B. burgdorferi lysate and then was mixed with equal 
quantity of with or without β-ME containing SDS loading buffer. The lysates in different combination of NEM 
and β-ME treated samples were immunoblotted using BBA52 antibody.  Arrow denotes the oligomerization 
tendency of BBA52. Treatment with NEM did not bring any change in migration pattern of BBA52 protein 
whereas in the absence of β-ME, BBA52 exists as oligomeric protein.  (C) Different strains of B. burgdorferi 
BBA52 exists as oligomeric protein.  B. burgdorferi strains, B31A3, 297 and N40 lysates, prepared in the presence 
or absence of β-ME were immunoblotted using BBA52 antibody.  All the three strains follows similar pattern of 
BBA52 oligomerization, marked by arrow. (D) NEM treatment to protoplasmic cylinder (PC) fraction of B. 
burgdorferi.  Protoplasmic cylinder fraction was isolated from WT B. burgdorferi to analyze the location where 
disulfide modification takes place.  PC fractions of B. burgdorferi in the presence or absence of NEM and β-ME 
were immunoblotted with BBA52 antibody.  Arrows show that the oligomerization occur only in the absence of β-
ME.  (E). Immunoblot using OspC antibody on NEM and β-ME treated B. burgdorferi lysate.  Arrows show that 
oligomerization of OspC, a known disulfide bond forming protein, is not inhibited in the presence or absence of 








from the feeding ticks to a naïve murine host.  To mimic the natural transmission process, 
we generated B. burgdorferi-infected nymphs by allowing larvae to acquire spirochetes 
from infected mice and then molt into nymphs.  A microinjection procedure (Pal et al., 
2004b) was used to deliver similar amounts of normal rabbit antibodies or BBA52 
antibodies that recognized the extracellular part of the antigen (FIGURE 14B) into the 














Figure 16.   Characterization of BBA52 antibodies. 
 (A) BBA52 antibodies bind to the surface of intact unfixed B. burgdorferi (arrow).  Spirochetes were 
immobilized on glass slides and probed with BBA52 or control (GST) antibodies.  Antibody against known 
surface (OspA) and subsurface (BBA62) spirochete proteins were used as controls.  Spirochete loading and 
antibody labeling was assessed using propidium iodide (PI) and Alexa-488 tagged secondary antibodies, 
respectively.  Images were acquired using a 40x objective lens of a Zeiss confocal microscope.  (B) Borreliacidal 
activities of BBA52 antibodies in vitro.  Spirochetes were incubated with either normal rabbit sera (NRS), rabbit 
OspA antibodies (OspA), serum collected from 15-day infected mice or BBA52 antibodies.  The sensitivity of 
spirochetes to the bactericidal effects of the antibodies was assessed by a re-growth assay after 48 h of antibody 
incubation and presented as mean ± SEM of viable spirochete number (cells/ml).  The numbers of viable 
spirochetes were significantly reduced in the samples exposed to the OspA or B. burgdorferi antibodies, 






























Figure 17.  In vitro growth kinetics of bba52 mutant and WT B. burgdorferi at 37°C and 25°C. 
 (A) Spirochetes were grown at 37°C in BSK medium, starting from 10
5
 B. burgdorferi per ml and were 
counted until day 6 using Petroff-Hausser counting chamber. (B). Spirochetes were grown at 25°C in BSK 
medium, starting from 10
5
 B. burgdorferi per ml and was counted until day 4. The values are shown as 
average of two counts from single experiment. 
 
Figure 18.   Osmotic stress using 1 M Sodium chloride on bba52 mutant B. burgdorferi culture. 
  Stationary phase B. burgdorferi of WT and bba52 mutant cultures were incubated with 1 M 
NaCl or equal amount of sterile water for 40 min at 34°C.  After incubation 40 min of osmotic 
stress, equal volume of spirochetes were recultured for 48 h  at 37°C and were counted in 1:10 
dilution under dark field microscopy. There was no effect on giving osmotic stress to bba52 






























Figure 19.  Effects of Oxidative stress on bba52 mutant B. burgdorferi using different concentration of Hydrogen 
per oxide.  
 B. burgdorferi were grown in BSK in the presence of 1 mM and 10 mM Hydrogen per oxide for 24 h at 34°C.  
After incubation in the presence or absence of Hydrogen peroxide, equal volume of the culture was was re-grown 
in fresh BSK medium for 24 h and the number of live B. burgdorferi was counted twice from single experiment.  
Number of live B. burgdorferi is represented in terms of the percentage of the untreated samples. The values are 
shown as average of two counts from single experiment. 
 
 
Figure 20.  Determination of outer membrane integrity of bba52 mutant B. burgdorferi using Sodium 
dodecyl sulfate (SDS).   
Spirochetes in BSK medium (10
7 
cells/ml) were incubated in presence of SDS (2 mg/ml) for 4 h at 34°C.  As 
a standard, WT spirochetes was incubated with 10 mg/ml SDS considering as a hundred percent destruction 
of outer membrane.  DNA was extracted from equal aliquots of supernatants of each samples and analyzed 
by qPCR as percentage of released DNA in terms of standard. There was no effect on the integrity of outer 





4.3.2 BBA52 is a potential target for transmission-blocking Lyme disease vaccine 
 
As BBA52 is exposed on the microbial surface and primarily produced in ticks, I 
explored whether BBA52 antibodies, despite lacking borreliacidal properties (FIGURE 
21B & 16B) could interfere with BBA52 function in vivo and influence the transmission 
of B. burgdorferi from the feeding ticks to a naïve murine host.  To mimic the natural 
transmission process, B. burgdorferi-infected nymphs was generated by allowing larvae 
to acquire spirochetes from infected mice and then molt into nymphs.  A microinjection 
procedure (Pal et al., 2004b) was used to deliver similar amounts of normal rabbit 
antibodies or BBA52 antibodies that recognized the extracellular part of the antigen 
(FIGURE 14B) into the tick gut.  Following infection, one group of ticks remained in the 
unfed condition for 5 days, while a parallel group was allowed to feed on naïve C3H 
mice for 72 h.  The spirochete burden in ticks were determined by confocal 
immunofluorescence (FIGURE 21A) and qRT-PCR (FIGURE 21B), which indicated that 
BBA52 antibody did not affect persistence of B. burgdorferi in unfed ticks.  Strikingly, 
qRT-PCR analysis of mouse infection following one week of tick engorgement indicated 
that, unlike the control antibody, BBA52 antibody treatment effectively blocked the 
transmission of spirochetes from ticks to mice (FIGURE 21C).  The culture analyses 
corroborated with these data by the observation that while B. burgdorferi was readily 
recovered from murine skin, spleen and heart tissues in control antibody-treated groups, 
while the mice fed by BBA52 antibody-treated ticks remained culture negative at all 
tissue locations.  
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I next assessed whether BBA52 antibodies generated in mice via active 
immunization could interfere with BBA52 function in the feeding vector and influence 
the transmission of B. burgdorferi from ticks to naïve hosts.  To accomplish this, separate 
















Figure 21.  Non-borreliacidal BBA52 antibody does not interfere with microbial persistence in feeding ticks but blocks 
pathogen transmission from ticks to mice.  
 (A) BBA52 antibodies failed to interfere with the spirochete persistence in unfed ticks.  Naturally-infected nymphal 
ticks were microinjected with antibodies against BBA52 (Anti-BBA52 Ab) or control antibody (Normal rabbit Ab) and 
spirochete distribution in the gut of unfed ticks were analyzed at 5 days after injection.  The spirochetes (arrow) were 
labeled with FITC-labeled goat anti-B. burgdorferi antibody (shown in green), and the nuclei of the gut cells were 
stained with propidium iodide (shown in red).  Images were obtained using a confocal immunofluorescence 
microscope and presented as merged image for clarity.  (B)  Quantitative representation of the data shown in Figure 
21A.  B. burgdorferi burden in ticks were assessed by qRT-PCR analysis by measuring copies of the B. burgdorferi 
flaB RNA and normalize against tick β-actin levels.   Bars represent the mean  SEM of four qRT-PCR analyses 
derived from two independent infection experiments.  Differences in the spirochete burden in unfed ticks passively 
transferred with BBA52 antibody and those with the control were insignificant (P > 0.05). (C) BBA52 antibodies 
blocked transmission of B. burgdorferi from ticks to mice.  Naturally infected nymphal ticks were microinjected with 
antibodies as described above and placed on naïve mice 48 h after injection.  Ticks were allowed to fully engorge on 
mice and the transmission of B. burgdorferi was assessed by measuring copies of the B. burgdorferi flaB gene in the 
indicated murine tissues 7 days after tick feeding.  Amounts of mouse β-actin were determined in each sample and 
used to normalize the quantities of B. burgdorferi flaB.  Bars represent the mean ± SEM of relative tissue levels of B. 














animals/group) were actively immunized with either recombinant BBA52, purified as 
full-length protein or PBS (control) mixed with similar volume of adjuvant.  ELISA and 
immunoblotting performed after the final boosting indicated that immunized mice had 
developed a strong antibody titer that specifically recognized recombinant and native 
BBA52.  Ten days after the final immunization, mice were parasitized by B. burgdorferi-
infected nymphs (2 ticks/mouse).  The spirochete burdens in engorged ticks were 
determined by qRT-PCR, which indicated that BBA52 antibody did not affect persistence 
of B. burgdorferi in feeding ticks.  Strikingly, qRT-PCR analysis of mouse infection 
following one week of tick engorgement indicated that, unlike the control, BBA52 
immunization effectively blocked the transmission of spirochetes from ticks to mice 
 
Figure 22. Active immunization of mice with recombinant BBA52 significantly interfere with spirochete 
transmission from infected ticks.  
A group of 5 mice were immunized with PBS or recombinant BBA52.  At day 5 of second boosting, two 
naturally infected ticks with Borrelia burgdorferi were infested on each mouse until complete feeding.  At 
day 10 of tick transmission mice were sacrificed and tissue samples were collected to generate cDNA and 
analyze the spirochete load in each tissue by qRT-PCR as copies of flaB/10
7 
β-actin. Three independent 
experiments were performed and the average values were analyzed statistically.  Bars represent the mean ± 
SEM of relative tissue levels of B. burgdorferi from three independent animal experiments.  Asterisk denotes 
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(FIGURE 22).  However, in spite of significantly impaired transmission, spirochetes were 
still recovered by culture analyses of BBA52-immunized infected murine tissues.  
These data establish that BBA52 facilitates B. burgdorferi transition from feeding 
ticks to the murine hosts and potentially serve as an antigenic target to interfere with the 
B. burgdorferi transmission.  
4.3.3 Interaction of recombinant BBA52 protein with B. burgdorferi proteins  
BBA52 is a unique and highly conserved protein, in B. burgdorferi sensu stricto, 
expressed only in B. burgdorferi, in reference to the current data base availability.  As 
BBA52 display no similarities with known proteins, identification of molecular function 
of BBA52 in spirochete biology remains as a challenging preposition. I next assessed if 
BBA52 is involved in protein-protein interaction.  A gel overlay assay using rBBA52 as a 
bait and the wild type and BBA52 mutant lysates as prey protein were performed that 
showed two possible interacting partners of recombinant BBA52 (FIGURE 24).  One of 
the BBA52-interacting protein has the same molecular weight as BBA52 (33 kDa) and 
the second partner is above 25 kDa in molecular weight (FIGURE 24 A & C).  To 
localize the interacting partner, outer membrane vesicle and protoplasmic cylinder of WT 
and mutant B. burgdorferi was extracted, and resolved on SDS-PAGE and transferred on 
nitrocellulose membrane as prey proteins, followed by overlay with rBBA52 as a bait 
protein to analyze by far western technique.  It was observed that the 25 kDa interacting 
partner was localized in the protoplasmic cylinder content whereas the 33 kDa partner 
was localized in both outer membrane vesicle and the protoplasmic cylinder (FIGURE 
23).  This finding was further confirmed by performing far-western analysis using the 
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wild type B. burgdorferi lysate and rBBA52 protein.  The bound protein was detected 
using anti-His IgG HRPO conjugate (FIGURE 24A).  To identify the interacting partners, 
I performed two dimensional (2D) gel electrophoresis.  The wild type B. burgdorferi 
lysate was resolved using IPG strip ranging from pH 3-10 in triplicates, on Ettan IPG 
phor as described in section 4.2.15.  After separation of individual B. burgdorferi proteins 
based on their isolectectric point, the strip was transferred carefully to resolve by the 
second dimensional SDS-PAGE.  One of the triplicate gels was stained with Coomassie 
stain and the other two gels was transferred on nitrocellulose membranes to detect the 
interacting partners by far-western, using with and without recombinant BBA52 overlay 
(FIGURE 24C).  The spot where BBA52 interacting partner was found by far-western 
was excised from the SDS-PAGE gel after Coomassie staining, protein were eluted from 
the gel, digested with trypsin and processed for protein identification by Liquid-
chromatography (LC)-mass spectrophotometry (MS) (FIGURE 24B).  To further validate 
the mass spectrophotometric data, another independent pull down assay was performed 
using 6×His tag rBBA52 bound to Probond Nickel column resins (Invitrogen).  Outer 
membrane vesicles (OMV) and protoplasmic cylinder (PC) fractions from BBA52 mutant 
was purified from 1 liter culture of BSK, as described in section 4.2.3.  The OMV and PC 
fractions were suspended with the rBBA52 bound to Probond Nickel column resin 
separately and incubated overnight at 4°C on a slow rocking platform.  After overnight 
shaking, the unbound proteins were removed by several washing with PBS.  The bound 
rBBA52 protein with the B. burgdorferi interacting partners was eluted by SDS-PAGE 
sample buffer (Bio-Rad) at 95°C for 10 min.  Elute obtained was resolved on SDS-
PAGE, stained with Coomassie and the protein bands at 33 kDa and 25 kDa were excised 
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from the gel  and processed for protein identification using LC- MS/MS analysis.  
Common proteins identified by MS analysis in two independent experiments were 
analyzed for their expression profile from in vitro and in vivo (mouse and tick) 
transcriptome of B. burgdorferi (FIGURE 25).  The MS identified spirochete genes 
bbi36, bbi38, bbi39 and bbj41 were to be the closest match in terms of molecular weight 
and expression pattern with bba52.   The interaction of BBA52 with 33 kDa and 25 kDa 
protein remains a subject of further investigation, which might shed light to the role of 
































Figure 23. BBA52 interacts with B. burgdorferi proteins.  
 Outer membrane vesicles (OMV) and protoplasmic cylinder (PC) were separated from WT and BBA52 
mutant B. burgdorferi. Each sample was heated with or without β-mercaptoethanol and was resolved on 
SDS-PAGE and then transferred to nitrocellulose membranes, blocked with 5% milk.  Membranes were 
incubated overnight in the absence or presence of 5-10 µg of rBBA52. Each membrane was then probed 
with anti BBA52 followed by anti-mouse HRPO. Two interacting partners in the OMV and PC fraction 






















Figure 24. Identification of BBA52 interacting proteins by far-western assay involving one and two-
dimensional SDS-PAGE gels. 
(A) Far-western analysis was performed using B. burgdorferi lysates resolved using one-dimensional 
SDS-PAGE and overlaying with rBBA52. The membrane was probed with anti-His HRPO conjugate to 
detect rBBA52 containing amino terminal His tag. Two binding partners were detected at 33 kDa and 25 
kDa molecular weight. (B) Coomassie stained 2D gel of wild type B. burgdorferi lysates. Some insoluble 
fractions of the protein failed to separate in the one dimension, as marked by arrows. (C) Far-western 
performed on the 2D gel transferred nitrocellulose membrane using rBBA52 as overlay protein. The 
membrane was probed with anti-His HRPO conjugate.  Two spots are visible, as marked by asterisks 
were the possible BBA52 interacting partners. The white arrows indicate BBA52 interacting proteins 













Sequence (5  3: Forward, Reverse) 
BBI36/I3
8/I39/J41 
antigen, P35, putative 54 GTGAAAAAGAAGCCGAAAAGT,  
TAGTAGATAAAGAGGATGGGAATA 
BB0057 gap  CAGATCCTAAAACTCTTGCACATCT, 
CTGATGAAAAAACACCTGTTGACT 
BB0141 








BB0334 OppD 13 TCCGTAACAAGTATGGCTATTTTAAA, 
AAGTTGAGTTGATATTCTTAAAAATGG 
BB0418 HP  ACCCAAGTTTAAAAATTCCAGTCA, 
AAGCAATAGGAGTAAAGCTTACTGTG 
BB0176 AAA, putative  GAAATGATAGATGCTATTTTAATGGGT, 
AGTGCCTGTAGCACTTTTATAAACC 
BBI36 
antigen, P35, putative  ATACTATTAAGCTTAACGTTATTACAGCAATATT, 
TGCTGAATTTTCTGAATTGGTG 
BBI39 
















4.3.4 Interaction of BBA52 with Ixodes scapularis tick gut extract 
Since, BBA52 is surface localized B. burgdorferi protein and expressed during 
migration in ticks, I proceded to investigate for its interacting partners in tick gut.  ELISA 
was performed after coating the tick gut extract in a microtiter plate as described in 
section 4.2.13.  The binding was measured using TMB microwell peroxidase substrate 
(KPL Gaithersburg, MD) for color development.  The OD was measured at 450 nm after 
adding stop solution at 15 min of color development.  The binding study showed that 
there was specific binding of rBBA52 protein with the tick gut extract compared to the 
control protein glutathione s-transferase (FIGURE 26A).  The result was further 
 
Figure 25. Expression analysis of the BBA52 interacting borrelial gene products. 
Total RNA was isolated from cultured spirochetes; from pooled B. burgdorferi–infected nymphs collected at 24, 
48, and 96 h of feeding on naive mice; and from murine skin after 2 weeks of B. burgdorferi infection.  Total 
RNA was converted to complementary DNA for measuring-specific transcripts by qRT-PCR and normalized 




supported by visualizing the interaction of BBA52 with the tick gut using confocal 
microscopy.  The rBBA52 protein binding was specific as the control protein rBBA62 
which is known to be sub-surface localized protein in B. burgdorferi, doesn‟t show any 
interaction with the tick gut (FIGURE 26B).  To screen the nature of BBA52 receptor in 















Figure 26. Interaction of rBBA52 with tick gut.  
(A) ELISA showing interaction of rBBA52 to tick gut lysate. Tick gut extract (TGE) was coated overnight in a 
microtiter well plate, which was then overlayed with rBBA52 protein or GST and BSA as control. The interaction 
with BBA52 and tick gut protein was probed using anti BBA52 antibody as described in materials and methods. 
It shows rBBA52 interacts strongly with tick gut. (B). Confocal analysis of rBBA52 interaction with tick gut. The 
interaction was visualized by using anti-mouse IgG tagged with Alexa 488.  For control BBA62 was overlayed 
on it which doesn‟t show any specific interaction unlike BBA52. Tick gut nucleic acid was stained with 
Propidium Iodide (PI), to visualize the gut tissue. (C) Interaction study of tick gut extract with rBBA52 after 
trypsin (T) treatment. Equal aliquots of Tick gut extract suspended in PBS were incubated with trypsin (Sigma) 
for 1 h at 37°C at 10 µg /ml in the presence or absence of 20 µg of soyabean trypsin inhibitor (I) (Sigma)/ml.  
After 1 h of enzymatic digestion of tick gut protein, the TGE and the enzyme treated samples were coated on 


















gut, tick gut extract were trypsinized (T) in the presence or absence of soyabean trypsin 
inhibitor (I) (Both from Sigma).  The samples were coated in a microtiter plate and the 
interaction of BBA52 was investigated as described in section 4.2.14.  Trypsinization 
experiment provided the evidence that BBA52 receptor in tick gut is protein in nature, 
 
Figure 27. Far western analysis for identification of recombinant BBA52 receptor in the tick gut. 
  Tick gut proteins were resolved using SDS-PAGE gels and transferred to nitrocellulose membrane.  
The membrane was blocked with 5% of skimmed milk and incubated with 5-10 µg of recombinant 
BBA52. Parallel control lanes were incubated in the buffer without recombinant BBA52. The 
membrane was finally washed with PBS-Tween 20 (0.05%) and then was probed with anti-BBA52 and 





since there was a reduction of interaction in the wells which were coated with trypsinized 
tick gut extract whereas gut extract containing soyabean trypsin inhibitor did not 
influence the BBA52 interaction with its tick receptor (FIGURE 26C).  Far-western 
analysis using the 48 h uninfected fed tick gut and rBBA52 as overlay protein, showed ~ 
35 kDa interacting partner in the tick gut (FIGURE 27).  From my findings, BBA52 
appears to be sandwiched between the B. burgdorferi outer membrane and a tick gut 





B. burgdorferi is unique among the pathogenic spirochetes by requiring obligate 
blood-feeding arthropods for their transmission and maintenance in susceptible vertebrate 
host populations (Canale-Parola, 1984).  B. burgdorferi does not readily infect most tick 
species, suggesting that the interactions between I. scapularis and B. burgdorferi are 
highly specific, and limited studies have shed important light on the complex interactions 
between B. burgdorferi and ticks (de Silva AM, 2009; Fikrig and Narasimhan, 2006; 
Munderloh and Kurtti, 1995; Tsao, 2009).   I identified bba52 as one of the genes that is 
selectively expressed in ticks and showed that BBA52 is a surface exposed protein, which 
can specifically interact to an uncharacterized-tick gut protein.  Analysis of surface 
exposure of BBA52 by subcellular fractionation of OM, PK assay, and 
immunofluorescence studies provides solid evidences that BBA52 is localized in the OM 
and exposed to the surface.  The phase partition of B. burgdorferi proteins in solution of 
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Triton X-114 showed BBA52 to be present in both aqueous and detergent phase, 
suggesting BBA52 to be amphiphlic in nature and partly integrated to membrane.  
Antibodies against BBA52 partially but significantly blocked B. burgdorferi transmission 
from ticks to mammals, indicating that the antigen might contribute to development of a 
transmission-blocking Lyme disease vaccine.   
Although I have determined that BBA52 participates in pathogen transitions 
between the host and the vector, with the most prominent role during pathogen exit from 
ticks to mice, the function of this gene product in spirochete biology remains unknown.  
No phenotypic effects of bba52 deletion were evident in vitro, when mutants were 
exposed to varied temperature, osmotic and oxidative shock or detergents.  Therefore, 
BBA52 is not likely to be involved in spirochete growth, stress response or membrane 
integrity, at least in vitro.  Attempts for generation of recombinant BBA52 protein in 
bacterial cells seems to exert toxic effect, as E. coli was unable to grow properly when 
BBA52 expression was induced.  I successfully produced the recombinant BBA52 in 
insect cells using baculovirus expression system.  I also show that BBA52 protein in B. 
burgdorferi appeared to occur as homooligomers possibly through inter- and 
intramolecular disulfide bond formation.  I have detected several oligomeric forms of 
BBA52 which includes monomer, dimer, trimer and hexamer that appear to be resolved 
in SDS-PAGE gel as doublets of close proximity.  The doublet form of native BBA52 
could be due to difference in the protein configuration.  This pattern of oligomerization of  
B. burgdorferi protein is very rarely reported, except for OspC (Kumaran et al., 2001) 
and CRASP1 proteins (Cordes et al., 2005).  However, this is puzzling as B. burgdorferi 
genome lacks orthologs of bacterial enzymes involved in the formation of disulfide bond 
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(Dutton et al., 2008).  Disulfide bonds in proteins play an important protective role 
for microbes, as it may function as a  reversible switch to regulate protein activity 
(Ladenstein and Ren, 2008).  However, I did not find any difference in the ability of 
bba52 mutant and parental isolates for growth under different Hydrogen per oxide 
concentrations.  Moreover, native BBA52 in borrelial cells is likely to be subjected to 
disulfide modification as treatment with N-Ethylmaleimide, which prevents artificial 
disulfide bond formation in lysed cells or solublized proteins, also demonstrated 
oligomerization property of native BBA52.  It appears that BBA52 is more stable as a 
trimer compared to dimeric and hexameric forms.    
My data suggest that correlated with tick-specific expression of bba52 and 
significant extracellular exposure of the antigen, BBA52 might be involved in pathogen 
interaction with vector environment.  In the trypsin digested tick gut, BBA52 failed to 
show interaction with the tick gut receptor, showing possible existence of protein 
receptor for BBA52.  In agreement with genetic studies, BBA52 antibody interfered with 
the transmission of spirochetes to naïve mice.  BBA52 antibody did not show 
borreliacidal activities in vitro or cause significant changes in the feeding behavior of 
ticks, gut morphology or distribution of spirochetes in unfed ticks.  This suggests that the 
effects of the BBA52 antibody on spirochete transmission were not likely due to the 
bactericidal action of the antibody or indirect effects on tick biology, but potentially, 
through interfering with BBA52 interaction with the vector environment.  So, I attempted 
to study its function by following an indirect approach.  Since, BBA52 is an OM protein 
and expressed only in vector-specific spirochete life cycle, it could interact with both tick 
and other borrelial proteins.  I identified two possible B. burgdorferi proteins that 
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interacted with BBA52.  Although precise identity of these proteins remains significant 
future efforts, I preliminarily identified one of these BBA52-interacting proteins as 
BBI36, BBI38, BBI39, or BBJ41.  Based on protein sequence analyses, these display 91-
99% homology.  Specifically, BBI36 and BBI38 & BBI39 and BBJ41 have 99% 
similarity.  Analyses of their gene expression in vivo show that bbi39 has the similar 
expression pattern like BBA52 while bbi36 is not expressed. The primers for bbi36 and 
bbi39 were designed against the non consensus nucleotide sequence for qRT-PCR.  Thus, 
I ruled out the possibility of BBI36 as interacting partner of BBA52 but I cannot 
differentiate the expression pattern of bbi39 and bbj41 due to 99.5% sequence homology.  
Since, this protein also turned out to be a hypothetical protein; I have not been able to 
predict the function of BBA52.  Further investigation is required to study the interaction 
of BBA52 with BBI39 to draw any conclusion.  
Similar to borrelial protein, I identified a tick protein of 35 kDa also interact with 
BBA52.  As tick proteome is remarkably diverse, I was unable to identify the BBA52 
receptor.  Future studies using yeast two hybrid assay or phase display assays could be 
executed to identify the BBA52 receptor in ticks.  Characterization of surface-exposed 
microbial antigens expressed in feeding arthropods provides an opportunity to understand 
the pathogen interactions with its environments likely required for microbial transition 
between hosts and vectors, and may contribute to development of novel transmission-





Chapter 5: Conclusions 
B. burgdorferi has evolved a remarkable capability for persistence in nature 
through a distinctive but diverse range of organisms, such as in I. scapularis ticks and 
wild rodents. Spirochete genes that are temporally induced in particular host or vector 
locations could be functionally important for B. burgdorferi persistence and transmission 
through the natural enzootic cycle.  My data show that selected B. burgdorferi genes are 
variably expressed in vivo, some of which are highly transcribed in feeding ticks during 
transmission.  The expression pattern of many of genes bb0323, bba52, bba62, bba74, 
bb0262, bb0769, bb0353, bb0213, bbg01, and bbe31 showed preferential upregulation of 
expression in ticks, whereas bb0028, bb0108, bb0319, bb0381, bbb27, bbl23, bbn39, 
bb0258, bb0298, bba73, bbj23, bbj27, bbm38, bbn26, bbn38  and bb0735 were 
preferentially upregulated in mouse.  A selective assessment of the microbial 
transcriptome, limited to putative membrane proteins, reveals that bba52 expression is 
only detectable in ticks and upregulated during pathogen transmission.  bba52 deletion 
did not affect murine inflammation or long-term pathogen persistence in mice or ticks, 
but did impair transitions between hosts and vector, a defect that could be rescued when 
native bba52 expression was genetically complemented.  I show that the antigen, which 
lacks homology to known proteins, is localized in the outer membrane, exposed 
extracellularly via the carboxyl terminus and potentially involved in pathogen-vector 
interaction.  Interference with BBA52 function, both through active immunization of 
mice and passive antibody transfer to ticks, impaired pathogen transmission from ticks to 
naïve hosts.  These studies establish that BBA52 facilitates vector-host transitions and as 
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